WO2014065517A1 - Hardening resin composition and optical film manufactured by using same - Google Patents

Hardening resin composition and optical film manufactured by using same Download PDF

Info

Publication number
WO2014065517A1
WO2014065517A1 PCT/KR2013/008783 KR2013008783W WO2014065517A1 WO 2014065517 A1 WO2014065517 A1 WO 2014065517A1 KR 2013008783 W KR2013008783 W KR 2013008783W WO 2014065517 A1 WO2014065517 A1 WO 2014065517A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
carbon atoms
formula
resin composition
monomer
Prior art date
Application number
PCT/KR2013/008783
Other languages
French (fr)
Korean (ko)
Inventor
송병훈
권태창
김은영
Original Assignee
동우화인켐 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 동우화인켐 주식회사 filed Critical 동우화인켐 주식회사
Publication of WO2014065517A1 publication Critical patent/WO2014065517A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10Esters
    • C08F20/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/10Optical coatings produced by application to, or surface treatment of, optical elements
    • G02B1/14Protective coatings, e.g. hard coatings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/102Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/103Esters of polyhydric alcohols or polyhydric phenols of trialcohols, e.g. trimethylolpropane tri(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10Esters
    • C08F222/1006Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/105Esters of polyhydric alcohols or polyhydric phenols of pentaalcohols
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/32Compounds containing nitrogen bound to oxygen
    • C08K5/33Oximes
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/02Diffusing elements; Afocal elements

Definitions

  • the present invention relates to a curable resin composition and an optical film produced using the same. More specifically, the present invention relates to a curable resin composition capable of photocuring and thermosetting, which can produce a resin layer having low energy consumption and excellent interlayer adhesion, and an optical film manufactured using the same.
  • optical films such as a polarizing film and a retarder, are used for the various image display apparatuses currently used.
  • Such an optical film is formed by stacking a plurality of thin films.
  • a retarder is normally formed by laminating
  • a base film the transparent film formed from TAC, COP, etc. is used, but the use of the base film which uses PMMA is increasing in recent years.
  • the filler when the filler is applied during the manufacturing process of the base film and the retarder, such a filler may be driven to the surface of the base film.
  • the surface roughness of the base film may increase.
  • the adhesive force between the base film and the alignment film is lowered, or the flatness of the cured liquid crystal layer is lowered on the alignment film, thereby degrading the function as a retarder. Penetration problems will occur.
  • An object of the present invention is to provide a curable resin composition capable of forming a resin layer having excellent interlayer adhesion.
  • an object of the present invention is to provide a curable resin composition capable of both photocuring and thermal curing to reduce energy during the manufacturing process.
  • an object of this invention is to provide the optical film provided with the resin layer formed from the said curable resin composition.
  • a photopolymerization initiator having at least two photoactive oxime ester backbones in one molecule;
  • Polyfunctional second monomer having a hydroxy group or a carboxy group;
  • an organic solvent
  • R 1 , R 2 and R 3 independently of one another represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN,
  • R 4 and R 5 are each independently R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN Represents a halogen atom or a hydroxy group,
  • a and b are each independently an integer of 0 to 3
  • R 11 , R 12 and R 13 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms
  • R 21 , R 22 and R 23 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Indicates,
  • the methylene group of the alkylene moiety of the substituent represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 is an unsaturated bond, ether bond, thioether bond, ester bond, thioester bond, amide bond or urethane It may be interrupted 1 to 5 times by a bond, the alkyl moiety of the substituent may have a branched chain, a cyclic alkyl, the alkyl terminal of the substituent may be an unsaturated bond, and R 12 , R 13 and R 22 and R 23 may each form a ring together, and R 3 may form a ring together with an adjacent benzene ring.)
  • R 1 to R 5 are as defined in 2 above.
  • the first monomer capable of photocuring and thermosetting including the isocyanate group and the (meth) acrylate group at its terminals is one or more selected from the group consisting of compounds of the formula Curable Resin Composition:
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • R 1 , R 2 , R 3 and R 4 is hydrogen or a carboxy group and the rest are independently selected from methyl or acryloyl groups, and A is , , , , or Is a integer of 1 to 3, b is an integer of 0 to 12).
  • the second monomer is a polystyrene reduced weight average molecular weight of 200 to 3,000 curable resin composition.
  • SP SUB is SP value of a base film
  • SP SOL is SP value of a solvent.
  • the base film is an optical film formed including the PMMA resin.
  • Image display device having the optical film of the above 10.
  • the curable resin composition of the present invention is excellent in interlayer adhesion, and in particular, when a reactive group having a carbon double bond is left in the adjacent film, it may also form a chemical bond therewith.
  • the curable resin composition of the present invention is capable of both photocuring and thermosetting, it is possible to advance the thermal curing during the drying process after applying the curable resin composition, and thus only the uncured portion after the drying process photocured Since it is possible to cure with only a low exposure amount can be saved energy.
  • the curable resin composition of the present invention when applied to a retarder using PMMA as the base film, when used as a resin layer between the alignment film and the base film, the surface of the base film becomes flat, so that the alignment film can be thickly formed. There is no need.
  • the present invention provides a photopolymerization initiator comprising a compound having at least two photoactive oxime ester skeletons in one molecule;
  • it comprises an organic solvent, excellent in interlayer adhesion, and a curable resin composition capable of photocuring and thermosetting, and relates to an optical film produced using the same.
  • Curable resin composition of this invention is a photoinitiator; A first monomer capable of photocuring and thermosetting; And polyfunctional second monomers.
  • the curable resin composition of the present invention comprises a photopolymerization initiator comprising a compound having at least two photoactive oxime ester skeletons in one molecule; A first monomer capable of photocuring and thermosetting by including an isocyanate group and a (meth) acrylate group at its terminals; And a polyfunctional second monomer having a hydroxy group or a carboxy group.
  • the photopolymerization initiator of the present invention includes a compound having two or more photoactive oxime esters skeleton in one molecule. Having two or more photoactive oxime ester skeletons in one molecule results in excellent polymerization initiation efficiency since two radicals are generated from one compound at the start of the polymerization reaction.
  • the compound having two or more photoactive oxime ester skeletons in one molecule is dimerized through R 1 or R 2 .
  • R 1 , R 2 and R 3 independently of one another represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN,
  • R 4 and R 5 are each independently R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN Represents a halogen atom or a hydroxy group,
  • a and b are each independently an integer of 0 to 3.
  • R 11 , R 12 and R 13 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms
  • R 21 , R 22 and R 23 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Indicates,
  • the methylene group of the alkylene moiety of the substituent represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 is an unsaturated bond, ether bond, thioether bond, ester bond, thioester bond, amide bond or urethane It may be interrupted 1 to 5 times by a bond, the alkyl moiety of the substituent may have a branched chain, a cyclic alkyl, the alkyl terminal of the substituent may be an unsaturated bond, and R 12 , R 13 and R 22 and R 23 may each form a ring together, and R 3 may form a ring together with an adjacent benzene ring.)
  • aryl group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 for example, phenyl, tolyl, xylyl, ethylphenyl, chlorophenyl, naphthyl, anthryl, phenanthrenyl, And phenyl, biphenylyl, naphthyl, anthryl and the like substituted with one or more of the above alkyl groups.
  • Examples of the arylalkyl group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 include benzyl, chlorobenzyl, ⁇ -methylbenzyl, ⁇ , ⁇ -dimethylbenzyl, phenylethyl and phenylethenyl Etc. can be mentioned.
  • heterocyclic group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 for example, pyridyl, pyrimidyl, furyl, thienyl, tetrahydrofuryl, dioxolanyl, benzoxazole- 2-yl, tetrahydropyranyl, pyrrolidyl, imidazolidil, pyrazolidyl, thiazolidyl, isothiazolidil, oxazolidyl, isoxazolidyl, piperidyl, piperazil, morpholinyl 5-7 membered heterocycles, such as these, are illustrated preferably.
  • ring which may be formed with a ring of benzene which R 12 and R 13 rings, which can be formed with R 22 and R 23 the ring, and R 3 which can form with the adjacent, for example, a cyclopentyl bullet, 5-7 membered rings, such as a cyclohexane ring, a cyclopentene ring, a benzene ring, a piperidine ring, a morpholine ring, a lactone ring, and a lactam ring, are mentioned.
  • Examples of the halogen atom that may be substituted for R 11 , R 12 , R 13 , R 21 , R 22 and R 23 and the halogen atom represented by R 4 , R 5 include fluorine, chlorine, bromine and iodine.
  • the methylene group of the alkylene moiety of the substituent may be interrupted 1 to 5 times by an unsaturated bond, an ether bond, a thioether bond, an ester bond, a thioester bond, an amide bond or a urethane bond, and at this time, one or more bond groups are interrupted Two or more types of contribution may also be sufficient, and when it is the group which can be interrupted continuously, you may interrupt 2 or more consecutively.
  • the alkyl part of the said substituent may have a branched side chain, cyclic alkyl may be sufficient, and the alkyl terminal of the said substituent may be an unsaturated bond.
  • R 1 is an alkyl group having 11 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, and a complex having 2 to 20 carbon atoms.
  • R 3 is an alkyl group having 1 to 12 carbon atoms interrupted 1 to 5 times by ether or ester bond, 13 to 20 carbon atoms
  • the methylene group of the moiety is a branched alkyl group having 8 or more carbon atoms which may be interrupted 1 to 5 times by an ether bond or ester bond;
  • the methylene group of the alkylene portion of the alkyl group is an alkyl group of 13 or more small atoms which may be interrupted 1 to 5 times by an ether bond or ester bond;
  • R 3 is an alkyl group interrupted 1 to 5 times by an ether bond; It is
  • the compound represented by Chemical Formula 1 is preferably dimerized through R 1 or R 2 .
  • R 1 to R 5 are as defined in Formula 1 above.
  • Preferred specific examples of the oxime ester compound of the present invention represented by Formula 1 include, but are not limited to, the compounds of Formulas 4 to 10 shown below.
  • the photopolymerization initiator having two or more photoactive oxime ester skeletons in one molecule may be included in an amount of 0.1 to 40% by weight based on the total weight of the curable resin composition of the present invention. Preferably, it may be included in an amount of 1 to 30% by weight. When included in the above content range, it exhibits high sensitivity to light, and thus the polymerization reaction proceeds sufficiently even at a low exposure amount, so that the interlayer adhesion is excellent.
  • the photopolymerization initiator contained in the curable resin composition of the present invention includes, but is not limited to, a triazine-based compound, an acetophenone-based compound, a biimidazole-based compound, and an oxime compound, in addition to the compound having two or more photoactive oxime ester skeletons in one molecule.
  • One or more compounds selected from the group can be used together.
  • Curable resin composition containing the said photoinitiator is highly sensitive, and the film
  • triazine type compound it is 2, 4-bis (trichloromethyl) -6- (4-methoxyphenyl) -1, 3, 5- triazine, 2, 4-bis (trichloromethyl)-, for example. 6- (4-methoxynaphthyl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6-piperonyl-1,3,5-triazine, 2,4- Bis (trichloromethyl) -6- (4-methoxystyryl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (5-methylfuran-2 -Yl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (furan-2-yl) ethenyl] -1,3,5-tri Azine, 2,4-bis (trichloromethyl) -6- [2- (4-diethyla
  • acetophenone type compound for example, diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl dimethyl ketal, 2-hydroxy-1- [4- ( 2-hydroxyethoxy) phenyl] -2-methylpropane-1-one, 1-hydroxycyclohexylphenyl ketone, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1 -One, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) butan-1-one, 2-hydroxy-2-methyl-1- [4- (1-methylvinyl) phenyl] And oligomers of propane-1-one.
  • R 1 to R 4 are independently a hydrogen atom, a halogen atom, a hydroxyl group, a phenyl group which may be substituted by an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms.
  • the naphthyl group which may be substituted by the benzyl group or C1-C12 alkyl group which may be substituted by this is shown.
  • Specific examples of the compound represented by Formula 12 include 2-methyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-ethyl-2-amino (4-morpholinophenyl) ethane- 1-one, 2-propyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-butyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-methyl- 2-amino (4-morpholinophenyl) propane-1-one, 2-methyl-2-amino (4-morpholinophenyl) butan-1-one, 2-ethyl-2-amino (4-morpholin Nophenyl) propane-1-one, 2-ethyl-2-amino (4-morpholinophenyl) butan-1-one, 2-methyl-2-methylamino (4-morpholinophenyl) propane-1- On, 2-methyl-2-dimethylamino (4-morpholinophenyl) propan-1-one, 2-methyl-2-die
  • biimidazole compound 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'- tetraphenyl biimidazole, 2,2'-bis (2,3-, for example) Dichlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetra (alkoxyphenyl) biimi Dazole, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetra (trialkoxyphenyl) biimidazole or a phenyl group at the 4,4', 5,5 'position
  • 2,2'bis (2-chlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole or 2,2'-bis (2,3-dichlorophenyl) -4,4', 5,5'-tetraphenylbiimidazole is preferably used.
  • Examples of the oxime compound include 0-ethoxycarbonyl- ⁇ -oxyimino-1-phenylpropan-1-one and the compounds represented by the following formulas (13) to (15).
  • photoinitiator etc. which are normally used in this field can also be used together, without departing from the scope of the present invention.
  • a benzoin compound, a benzophenone type compound, a thioxanthone type compound, an anthracene type compound etc. are mentioned, for example. These can be used individually or in combination of 2 or more types, respectively.
  • benzoin type compound benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, etc. are mentioned, for example.
  • benzophenone type compound for example, benzophenone, methyl 0- benzoyl benzoate, 4-phenyl benzophenone, 4-benzoyl-4'- methyl diphenyl sulfide, 3, 3 ', 4, 4'- tetra ( tert-butylperoxycarbonyl) benzophenone, 2,4,6-trimethylbenzophenone, etc. are mentioned.
  • thioxanthone type compound 2-isopropyl thioxanthone, 2, 4- diethyl thioxanthone, 2, 4- dichloro thioxanthone, 1-chloro-4- propoxy thioxanthone, etc. are mentioned, for example. Can be mentioned.
  • anthracene-based compound examples include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, and the like. Can be mentioned.
  • curable resin composition containing these is more sensitive and productivity at the time of forming a resin layer using this composition is preferable, it is preferable.
  • an amine compound and a carboxylic acid compound are preferably used.
  • amine compound in the photopolymerization initiation aid examples include aliphatic amine compounds such as triethanolamine, methyldiethanolamine, and triisopropanol amine, 4-dimethylaminobenzoate methyl, 4-dimethylaminobenzoate ethyl, 4-dimethylaminobenzoic acid, and pediatric wheat.
  • carboxylic acid compound examples include phenylthioacetic acid, methylphenylthioacetic acid, ethylphenylthioacetic acid, methylethyl phenylthioacetic acid, dimethylphenylthioacetic acid, methoxyphenylthioacetic acid, dimethoxyphenylthioacetic acid, chlorophenylthioacetic acid, dichloro And aromatic heteroacetic acids such as phenylthioacetic acid, N-phenylglycine, phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, and naphthoxyacetic acid.
  • the content of the photopolymerization initiation aid may be usually 0.1 to 40% by weight based on the total weight of the curable resin composition. Preferably it may be included in 0.5 to 30% by weight.
  • the content of the photopolymerization initiation aid is in the above range, the sensitivity of the curable resin composition is higher, and thus the formation of the resin layer formed by using the composition is preferable.
  • the first monomer according to the present invention is characterized by including an isocyanate group and a (meth) acrylate group at its terminals to enable photocuring and thermosetting.
  • the (meth) acrylate group participates in the photocuring reaction
  • the isocyanate group participates in the thermosetting reaction.
  • (Meth) acrylate groups react with carbon-carbon double bonds of other molecules to form carbon-carbon saturated bonds
  • isocyanate groups react with hydroxyl or carboxyl groups of the second monomer to form urethane bonds.
  • the isocyanate group of the first monomer is reacted with a hydroxyl group or a carboxyl group at a temperature of about 80 to 130 ° C., which is the temperature of a typical drying step carried out in the process of producing an optical film (thermosetting).
  • the first monomer is crosslinked with the second monomer, the hardness and the adhesion of the resin layer can be enhanced.
  • the (meth) acrylate group of the first monomer reacts with the unreacted carbon-carbon unsaturated bond reactive group remaining on the surface of the PMMA when the base film to which the resin layer is in contact is made of PMMA to form a carbon-carbon saturated bond. It may be formed. In this case, the resin layer and the base film may be connected by chemical bonding to have a stronger interlayer adhesion.
  • Examples of the first monomer according to the present invention include at least one selected from the group consisting of compounds represented by the following Chemical Formulas 16 to 19.
  • R 1 and R 2 are each independently hydrogen or a methyl group
  • R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
  • R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
  • R 7 and R 8 are each independently hydrogen or a methyl group
  • R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
  • R 10 is (a) Or (b) E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
  • R 12 is hydrogen or a methyl group
  • R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group;
  • R 14 is hydrogen or a methyl group
  • R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  • the first monomer represented by the above formulas (16) to (19) is at least one of the compounds represented by the formulas (17) to (19) and the compound represented by the formula (16) in order to ensure better interlayer adhesion It can be used as a mixture of.
  • More specific examples of the first monomer of Formula 16 to Formula 19 may include at least one selected from the group consisting of compounds represented by Formula 20 to Formula 30:
  • the first monomer according to the present invention is preferably included in 5 to 90% by weight, preferably 10 to 70% by weight relative to the total weight of the composition. It is possible to secure sufficient adhesive strength in the above range, when excessively added, the adhesive strength is improved, but when applied to the optical film, other physical properties may be lowered.
  • composition for forming a curable resin layer of the present invention may further include a thermal polymerization initiator to promote thermal curing.
  • the thermal polymerization initiator usable in the present invention can be used without particular limitation as long as it is used in the art.
  • the second monomer according to the invention is characterized in that the polyfunctional monomer having a hydroxy group or a carboxyl group. As described above, the second monomer performs a crosslinking reaction through a hydroxy group or a carboxyl group, and, if necessary, also has a carbon-carbon unsaturated bond as a functional group, and may also perform a polymerization reaction.
  • R 1 , R 2 , R 3 and R 4 is hydrogen or a carboxy group and the rest are independently selected from methyl or acryloyl groups, and A is , , , , or Is a integer of 1 to 3, b is an integer of 0 to 12).
  • More specific examples of the compound represented by Chemical Formula 31 may include a compound represented by Chemical Formula 32 to Chemical Formula 39, but are not limited thereto.
  • the weight average molecular weight of polystyrene conversion of the 2nd monomer which concerns on this invention is 200-3,000, More preferably, it may be 500-1,000. If the weight average molecular weight of the second monomer exceeds 3,000, the dispersibility may be reduced, or the brightness of the optical film may be lowered because a stable dispersion is not obtained. If the molecular weight is less than 200, the brightness of the optical film may be lowered.
  • the second monomer according to the invention is preferably included in 5 to 60% by weight relative to the total weight of the composition. If the content is less than 5% by weight, the degree of curing may be lowered, and if it is more than 60% by weight, it may be detrimental to heat curing.
  • Curable resin composition of this invention contains the organic solvent which can melt
  • the organic solvent maintains the dissolution and proper viscosity of the components so that the composition exhibits the desired coating properties, processability, and the like.
  • organic solvent examples include a component capable of dissolving the above components, but preferably a solvent containing an oxygen atom, a solvent having an SP DS value of 1 or less and a solvent of 15 or more, represented by Equation 1 below. It is preferable to use a mixed solvent of
  • the degree of miscibility and corrosion between the solvent used in the curable composition and the base film to which the curable composition is applied can be known by correlation of the solubility parameter (SP) of the solvent and the base film.
  • SP solubility parameter
  • a solvent having an SP DS value of 1 or less represented by Equation 1 may corrode the surface of the base film to a predetermined amount or more.
  • the rainbow phenomenon may be prevented due to the occurrence of irregularities between the interfaces, and adhesion, coating property, and the like may be improved.
  • the degree of corrosion is large and the unevenness between the interfaces is too large, the haze value may increase, or whitening may occur, and mechanical properties, in particular, film strength and flex resistance may be reduced.
  • the SP of the base film and the solvent may use values known in the art, for example, the values set forth in VII / 671-VII / 714 of the Polymer Handbook (4th Ed. J. Brandrup et al.). Can be used.
  • SP can be defined as ( ⁇ H / V) 1/2, ⁇ H is the molar evaporation enthalpy, and V is the molar volume.
  • solvent that can be used include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol Ethyl methyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoethyl ether acetate, propylene glycol monomethyl ether Acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, methoxybutyl acetate, methoxypentyl acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl a
  • the organic solvent in the present invention may be included as the balance of the content of the components based on 100% by weight of the total weight of the composition in order to maintain an appropriate viscosity.
  • Curable resin composition of this invention may further contain additives, such as a filler, a hardening
  • additives such as a filler, a hardening
  • Curable resin composition of the present invention containing the above components are used in the optical film to improve the interlayer adhesion, in particular can be useful for the surface planarization of the film is not flat surface.
  • a resin layer is formed between the PMMA substrate and the alignment film to cover the irregularities on the surface of the PMMA substrate by the polymer beads, thereby securing flatness and ensuring the PMMA substrate and the alignment film. Adhesion between can be strengthened.
  • the retarder has a structure in which a base film, a resin layer formed of the composition of the present invention, an alignment film, and a cured liquid crystal layer are sequentially stacked, which will be described in detail below.
  • the base film according to the present invention can be used without particular limitation the base film commonly used in the art.
  • a transparent film is generally used as the base film in the art, and is, for example, a film including a triacetyl cellulose (TAC), a cyclo-olefin polymer (COP), a poly (methyl methacrylate) polymer, or the like.
  • the base film may be surface treated such as safonification treatment, remote plasma treatment, direct plasma treatment, monomer plasma treatment, or the like.
  • PMMA type base film it is preferable to disperse
  • the alignment film according to the present invention may be formed of a composition for forming an alignment film including an alignment agent, a polymerization initiator, and an organic solvent commonly used in the art.
  • an alignment agent an alignment agent conventionally used in the art may be used without particular limitation.
  • a polymer having a cinnamate group and having a weight average molecular weight of about 10,000-500,000 may be used, but is not limited thereto.
  • the polymerization initiator a photopolymerization initiator or a thermal polymerization initiator commonly used in the art may be used.
  • the photopolymerization initiator the photopolymerization initiators exemplified above may be used.
  • An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
  • the cured liquid crystal layer according to the present invention may be prepared by curing a composition comprising a liquid crystal compound, a polymerization initiator, and an organic solvent having a polymerizable functional group at the terminal, and as a polymerization initiator, a photopolymerization initiator commonly used in the art or A thermal polymerization initiator may be used, and the photopolymerization initiator exemplified above may be used as the photopolymerization initiator.
  • An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
  • a curable resin composition was prepared by mixing a photopolymerization initiator, a first monomer, a second monomer, a leveling agent, and an organic solvent in the composition shown in Table 1 below (unit: g).
  • Example 1-6 and Comparative Examples 1-5 were applied to the PMMA film, dried at 100 ° C. for 30 seconds, and then exposed to 30 mJ, respectively, to form a resin layer. After apply
  • RMS curable liquid crystal composition
  • the retarder of the embodiments provided with a cured layer according to the present invention can be confirmed that the overall excellent in terms of curing degree, surface roughness and interlayer adhesion of the resin layer compared to the retarder of the comparative examples.
  • Example 1 since the photopolymerization initiator has a dimerized structure, the photoactive site is twice as large as that in the conventional case, and it can be confirmed that other components are more excellent in curing degree than Example 2, which was used in the same manner.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

The present invention relates to a hardening resin composition and an optical film manufactured by using same, and more specifically, to a hardening resin composition and an optical film manufactured by using same, the hardening resin composition comprising: a photopolymerization initiator comprising a compound having at least two photoactive oxime ester structures in one molecule; a first monomer comprising an isocyanate group and a (meta) acrylate group at the terminal thereof and thus allowing hardening by photocuring and thermal curing; a multifunctional second monomer having a hydroxy group or a carboxyl group; and an organic acid, thereby having superior adhesive force between layers and hardening by photocuring and thermal curing.

Description

경화성 수지 조성물 및 이를 사용하여 제조된 광학필름Curable resin composition and optical film manufactured using the same
본 발명은 경화성 수지 조성물 및 이를 사용하여 제조된 광학필름에 관한 것이다. 보다 상세하게는 광경화 및 열경화가 가능하여 에너지 소모량이 적고 층간 접착력이 우수한 수지층을 제조할 수 있는 경화성 수지 조성물 및 이를 사용하여 제조된 광학필름에 관한 것이다.The present invention relates to a curable resin composition and an optical film produced using the same. More specifically, the present invention relates to a curable resin composition capable of photocuring and thermosetting, which can produce a resin layer having low energy consumption and excellent interlayer adhesion, and an optical film manufactured using the same.
현재 사용되고 있는 다양한 화상 표시 장치에는 편광 필름, 리타더 등의 다양한 광학 필름이 사용되고 있다. 이러한 광학 필름은 복수의 박막이 적층되어 형성된다. Various optical films, such as a polarizing film and a retarder, are used for the various image display apparatuses currently used. Such an optical film is formed by stacking a plurality of thin films.
리타더의 경우를 예로 들면, 리타더는 통상적으로 기재 필름, 배향막, 경화 액정층이 차례로 적층되어 형성된다. 기재 필름으로는 TAC, COP, 등으로 형성된 투명 필름이 사용되는데, 최근에는 PMMA를 사용하는 기재 필름의 사용이 증가하고 있는 추세이다.Taking the case of a retarder as an example, a retarder is normally formed by laminating | stacking a base film, an orientation film, and a cured liquid crystal layer sequentially. As a base film, the transparent film formed from TAC, COP, etc. is used, but the use of the base film which uses PMMA is increasing in recent years.
다만, PMMA는 TAC이나 COP에 비해 깨지기 쉬운(brittle) 성질을 가지고 있으므로, 그대로 사용할 경우에는 crack이 쉽게 발생하는 문제점이 있다. 따라서, 통상적으로는 고무 비드(rubber bead) 등의 충진제를 내부에 분산시키는 방법으로 상기 문제점을 해결한다.However, since PMMA has a brittle characteristic compared to TAC or COP, there is a problem that cracks are easily generated when used as it is. Therefore, this problem is usually solved by dispersing a filler such as a rubber bead in the interior thereof.
하지만, 상기와 같은 충진제는 기재 필름 및 리타더의 제조 과정 중 열을 가해지게 되면 기재 필름의 표면으로 몰리는 현상이 발생하는데, 이런 경우 기재 필름의 표면 조도가 커지는 문제가 발생할 수 있다. 기재 필름의 표면 조도가 커지게 되면, 기재 필름과 배향막 사이의 접착력이 저하되거나 배향막 상에 경화액정층의 평탄성이 저하되어 리타더로서의 기능이 저하되는 문제가 발생하고, 심한 경우에는 충진제가 배향막까지 침투하는 문제가 발생하게 된다.However, when the filler is applied during the manufacturing process of the base film and the retarder, such a filler may be driven to the surface of the base film. In this case, the surface roughness of the base film may increase. When the surface roughness of the base film is increased, the adhesive force between the base film and the alignment film is lowered, or the flatness of the cured liquid crystal layer is lowered on the alignment film, thereby degrading the function as a retarder. Penetration problems will occur.
이러한 문제를 해결하기 위해서 배향막을 보다 두껍게 형성하는 방법이 수행되고 있으나, 배향막이 두껍게 되면 배향막의 배향능이 저하되는 문제가 발생하게 되어 바람직한 해결책은 되지 않는다.In order to solve such a problem, a method of forming an alignment layer thicker has been performed, but when the alignment layer becomes thick, a problem arises in that the alignment capability of the alignment layer decreases, which is not a preferable solution.
따라서, 리타더 등의 광학 필름에 요구되는 광학 성능은 저하시키지 않으면서 접착력을 개선할 수 있는 새로운 해결책이 요구된다.Therefore, there is a need for a new solution that can improve the adhesive force without degrading the optical performance required for an optical film such as a retarder.
본 발명은 층간 접착력이 우수한 수지층을 형성할 수 있는 경화성 수지 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a curable resin composition capable of forming a resin layer having excellent interlayer adhesion.
또한, 본 발명은 광경화와 열경화가 모두 가능하여 제조 공정 시 에너지를 절감할 수 있는 경화성 수지 조성물을 제공하는 것을 목적으로 한다.In addition, an object of the present invention is to provide a curable resin composition capable of both photocuring and thermal curing to reduce energy during the manufacturing process.
또한, 본 발명은 상기 경화성 수지 조성물로 형성된 수지층을 구비한 광학 필름을 제공하는 것을 목적으로 한다.Moreover, an object of this invention is to provide the optical film provided with the resin layer formed from the said curable resin composition.
1. 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제; 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체; 히드록시기 또는 카르복시기를 갖는 다관능 제2 단량체; 및 유기용매를 포함하는 경화성 수지 조성물.1. a photopolymerization initiator having at least two photoactive oxime ester backbones in one molecule; A first monomer capable of photocuring and thermosetting by including an isocyanate group and a (meth) acrylate group at its terminals; Polyfunctional second monomer having a hydroxy group or a carboxy group; And an organic solvent.
2. 위 1에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 1로 표시되는 화합물이 R1 또는 R2를 통해 이량화된 것인 경화성 수지 조성물:2. The curable resin composition according to the above 1, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is dimerized through R 1 or R 2 .
[화학식 1][Formula 1]
Figure PCTKR2013008783-appb-I000001
Figure PCTKR2013008783-appb-I000001
(식 중, R1, R2 및 R3은 서로 독립적으로 R11, OR11, COR11, SR11, CONR12R13 또는 CN을 나타내고,Wherein R 1 , R 2 and R 3 independently of one another represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN,
R4 및 R5는 각각 독립적으로 R11, OR11, SR11, COR11, CONR12R13, NR12COR11, OCOR11, COOR11, SCOR11, OCSR11, COSR11, CSOR11, CN, 할로겐원자 또는 히드록시기를 나타내고,R 4 and R 5 are each independently R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN Represents a halogen atom or a hydroxy group,
a 및 b는 서로 독립적으로 0 내지 3인 정수이고,a and b are each independently an integer of 0 to 3,
R11, R12 및 R13은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며, 여기에서 알킬기, 아릴기, 아릴알킬기 및 복소환기의 수소원자는, 또한 R21, OR21, COR21, SR21, NR22R23, CON R22R23, -NR22-OR23, -NCOR22-OCOR23, -C(=N-OR21)-R22, -C(=N-OCOR21)-R22, CN, 할로겐원자, -CR21=CR22R23, -CO-CR21=CR22R23, OCO-CR21=CR22R23, O-C1-6알킬렌-OCOR21, COOR21, 에폭시기로 치환되어 있어도 되고, R 11 , R 12 and R 13 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Wherein the hydrogen atom of the alkyl group, aryl group, arylalkyl group and heterocyclic group is also R 21 , OR 21 , COR 21 , SR 21 , NR 22 R 23 , CON R 22 R 23 , -NR 22 -OR 23 , -NCOR 22 -OCOR 23 , -C (= N-OR 21 ) -R 22 , -C (= N-OCOR 21 ) -R 22 , CN, halogen atom, -CR 21 = CR 22 R 23 , -CO- CR 21 = CR 22 R 23 , OCO-CR 21 = CR 22 R 23 , OC 1-6 alkylene-OCOR 21 , COOR 21 , or may be substituted with an epoxy group,
R21, R22 및 R23은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며,R 21 , R 22 and R 23 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Indicates,
상기 R11, R12, R13, R21, R22 및 R23으로 표시되는 치환기의 알킬렌 부분의 메틸렌기는 불포화 결합, 에테르 결합, 티오에테르 결합, 에스테르 결합, 티오에스테르 결합, 아미드 결합 또는 우레탄 결합에 의해 1 내지 5회 중단되어 있어도 되고, 상기 치환기의 알킬 부분은 분기측쇄가 있어도 되고, 환상 알킬이어도 되며, 상기 치환기의 알킬 말단은 불포화 결합이어도 되고, 또한 R12와 R13및 R22와 R23은 각각 함께 환을 형성하고 있어도 되며, R3은 인접하는 벤젠환과 함께 환을 형성하고 있어도 된다.)The methylene group of the alkylene moiety of the substituent represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 is an unsaturated bond, ether bond, thioether bond, ester bond, thioester bond, amide bond or urethane It may be interrupted 1 to 5 times by a bond, the alkyl moiety of the substituent may have a branched chain, a cyclic alkyl, the alkyl terminal of the substituent may be an unsaturated bond, and R 12 , R 13 and R 22 and R 23 may each form a ring together, and R 3 may form a ring together with an adjacent benzene ring.)
3. 위 2에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 2 또는 화학식 3으로 표시되는 화합물인 경화성 수지 조성물:3. The curable resin composition according to the above 2, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is a compound represented by the following Chemical Formula 2 or Chemical Formula 3:
[화학식 2][Formula 2]
Figure PCTKR2013008783-appb-I000002
Figure PCTKR2013008783-appb-I000002
[화학식 3][Formula 3]
Figure PCTKR2013008783-appb-I000003
Figure PCTKR2013008783-appb-I000003
(식 중, R1 내지 R5는 위 2에서 정의된 바와 같음).Wherein R 1 to R 5 are as defined in 2 above.
4. 위 1에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 11로 표시되는 화합물인 것을 특징으로 하는 경화성 수지 조성물:4. The curable resin composition according to the above 1, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is a compound represented by the following formula (11):
[화학식 11][Formula 11]
Figure PCTKR2013008783-appb-I000004
Figure PCTKR2013008783-appb-I000004
5. 위 1에 있어서, 상기 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체는 하기 화학식 16 내지 19의 화합물로 이루어진 군에서 선택된 1 종 이상의 것인 경화성 수지 조성물:5. In the above 1, wherein the first monomer capable of photocuring and thermosetting including the isocyanate group and the (meth) acrylate group at its terminals is one or more selected from the group consisting of compounds of the formula Curable Resin Composition:
[화학식 16][Formula 16]
Figure PCTKR2013008783-appb-I000005
Figure PCTKR2013008783-appb-I000005
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 17][Formula 17]
Figure PCTKR2013008783-appb-I000006
Figure PCTKR2013008783-appb-I000006
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2013008783-appb-I000007
또는 (b)
Figure PCTKR2013008783-appb-I000008
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2013008783-appb-I000007
Or (b)
Figure PCTKR2013008783-appb-I000008
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 18][Formula 18]
Figure PCTKR2013008783-appb-I000009
Figure PCTKR2013008783-appb-I000009
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 19][Formula 19]
Figure PCTKR2013008783-appb-I000010
Figure PCTKR2013008783-appb-I000010
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
6. 위 1에 있어서, 상기 히드록시기를 갖는 다관능 제2 단량체는 하기 화학식 31로 표시되는 것인 경화성 수지 조성물:6. In the above 1, wherein the polyfunctional second monomer having a hydroxy group is a curable resin composition represented by the following formula 31:
[화학식 31][Formula 31]
Figure PCTKR2013008783-appb-I000011
Figure PCTKR2013008783-appb-I000011
(식 중, R1, R2, R3 및 R4 중 적어도 하나는 수소 또는 카르복시기이고 나머지는 서로 독립적으로 메틸기 또는 아크릴로일기에서 선택되며, A는
Figure PCTKR2013008783-appb-I000012
,
Figure PCTKR2013008783-appb-I000013
,
Figure PCTKR2013008783-appb-I000014
,
Figure PCTKR2013008783-appb-I000015
,
Figure PCTKR2013008783-appb-I000016
또는
Figure PCTKR2013008783-appb-I000017
에서 선택되며, a는 1 내지 3의 정수이고, b는 0 내지 12의 정수임).
Wherein at least one of R 1 , R 2 , R 3 and R 4 is hydrogen or a carboxy group and the rest are independently selected from methyl or acryloyl groups, and A is
Figure PCTKR2013008783-appb-I000012
,
Figure PCTKR2013008783-appb-I000013
,
Figure PCTKR2013008783-appb-I000014
,
Figure PCTKR2013008783-appb-I000015
,
Figure PCTKR2013008783-appb-I000016
or
Figure PCTKR2013008783-appb-I000017
Is a integer of 1 to 3, b is an integer of 0 to 12).
7. 위 1에 있어서, 제2 단량체는 폴리스티렌 환산의 중량평균 분자량이 200 내지 3,000인 경화성 수지 조성물.7. In the above 1, the second monomer is a polystyrene reduced weight average molecular weight of 200 to 3,000 curable resin composition.
8. 위 1에 있어서, 제1 단량체와 제2 단량체의 혼합 중량비는 제1 단량체:제2 단량체 = 1:1-2인 경화성 수지 조성물.8. In the above 1, wherein the mixed weight ratio of the first monomer and the second monomer is the first monomer: the second monomer = 1: 1-2 curable resin composition.
9. 위 1에 있어서, 상기 유기 용매는 하기 수학식 1로 표시되는 SPDS값이 1 이하인 용매와 15 이상인 용매의 혼합 용매인 경화성 수지 조성물:9. The curable resin composition according to the above 1, wherein the organic solvent is a mixed solvent of a solvent having an SP DS value of 1 or less and a solvent of 15 or more represented by Equation 1 below:
[수학식 1][Equation 1]
Figure PCTKR2013008783-appb-I000018
Figure PCTKR2013008783-appb-I000018
(식 중, SPSUB 는 기재 필름의 SP값이고, SPSOL 은 용매의 SP 값임).(In formula, SP SUB is SP value of a base film, SP SOL is SP value of a solvent.).
10. 위 1 내지 9 중 어느 한 항의 경화성 수지 조성물로 경화된 수지층을 구비하는 광학 필름.10. An optical film having a resin layer cured with the curable resin composition of any one of the above 1 to 9.
11. 위 10에 있어서, 상기 광학 필름은 리타더인 광학 필름.11. The optical film according to the above 10, wherein the optical film is a retarder.
12. 위 11에 있어서, 상기 리타더는 상기 수지층이 기재 필름과 배향막 사이에 개재되는 구조를 구비하는 광학 필름.12. The optical film according to the above 11, wherein the retarder has a structure in which the resin layer is interposed between the base film and the alignment layer.
13. 위 12에 있어서, 상기 기재 필름은 PMMA 수지를 포함하여 형성된 것인 광학 필름.13. In the above 12, wherein the base film is an optical film formed including the PMMA resin.
14. 위 13에 있어서, 상기 기재 필름과 수지층 사이에는 탄소-탄소 포화결합이 존재하는 광학 필름.14. In the above 13, wherein the carbon-carbon saturated bond is present between the base film and the resin layer.
15. 위 10의 광학 필름을 구비하는 화상 표시 장치.15. Image display device having the optical film of the above 10.
본 발명의 경화성 수지 조성물은 층간 접착력이 우수하며, 특히 인접한 필름에 탄소 이중결합을 갖는 반응성기가 잔류하고 있는 경우에는 이와 화학적 결합도 형성할 수 있다.The curable resin composition of the present invention is excellent in interlayer adhesion, and in particular, when a reactive group having a carbon double bond is left in the adjacent film, it may also form a chemical bond therewith.
또한, 본 발명의 경화성 수지 조성물은 광경화와 열경화가 모두 가능하므로, 경화성 수지 조성물을 도포한 후 건조 과정 중에 열경화를 진행시킬 수 있게 되고, 그에 따라 건조 과정 후 미경화된 부분만 광경화를 수행하면 되므로 저노광량만으로 경화가 가능하여 에너지를 절감할 수 있다.In addition, since the curable resin composition of the present invention is capable of both photocuring and thermosetting, it is possible to advance the thermal curing during the drying process after applying the curable resin composition, and thus only the uncured portion after the drying process photocured Since it is possible to cure with only a low exposure amount can be saved energy.
특히, 본 발명의 경화성 수지 조성물을 기재 필름으로 PMMA를 사용한 리타더에 적용할 경우에 배향막과 기재필름 사이에 수지층으로 사용되면, 기재 필름의 표면을 평탄화하는 기능을 하게 되므로 배향막을 두껍게 형성할 필요가 없게 된다.In particular, when the curable resin composition of the present invention is applied to a retarder using PMMA as the base film, when used as a resin layer between the alignment film and the base film, the surface of the base film becomes flat, so that the alignment film can be thickly formed. There is no need.
본 발명은 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 화합물을 포함하는 광중합 개시제; 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체; 히드록시기 또는 카르복시기를 갖는 다관능 제2 단량체; 및 유기용매를 포함함으로써, 층간 접착력이 우수하고 광경화 및 열경화가 가능한 경화성 수지 조성물 및 이를 사용하여 제조된 광학필름에 관한 것이다.The present invention provides a photopolymerization initiator comprising a compound having at least two photoactive oxime ester skeletons in one molecule; A first monomer capable of photocuring and thermosetting by including an isocyanate group and a (meth) acrylate group at its terminals; Polyfunctional second monomer having a hydroxy group or a carboxy group; And it comprises an organic solvent, excellent in interlayer adhesion, and a curable resin composition capable of photocuring and thermosetting, and relates to an optical film produced using the same.
이하 본 발명을 상세하게 설명하도록 한다.Hereinafter, the present invention will be described in detail.
본 발명의 경화성 수지 조성물은 광중합 개시제; 광경화 및 열경화가 가능한 제1 단량체; 및 다관능 제2 단량체를 포함한다.Curable resin composition of this invention is a photoinitiator; A first monomer capable of photocuring and thermosetting; And polyfunctional second monomers.
바람직하게는 본 발명의 경화성 수지 조성물은 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 화합물을 포함하는 광중합 개시제; 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체; 및 히드록시기 또는 카르복시기를 갖는 다관능 제2 단량체를 포함한다.Preferably, the curable resin composition of the present invention comprises a photopolymerization initiator comprising a compound having at least two photoactive oxime ester skeletons in one molecule; A first monomer capable of photocuring and thermosetting by including an isocyanate group and a (meth) acrylate group at its terminals; And a polyfunctional second monomer having a hydroxy group or a carboxy group.
본 발명의 광중합 개시제는 한 분자내에 2개 이상의 광활성 옥심 에스테르 골격을 갖는 화합물을 포함한다. 한 분자내에 2개 이상의 광활성 옥심 에스테르 골격을 갖게 되면 중합 반응을 개시할 때 한 화합물에서 2 개의 라디칼이 생성되므로 중합 개시 효율이 우수하다.The photopolymerization initiator of the present invention includes a compound having two or more photoactive oxime esters skeleton in one molecule. Having two or more photoactive oxime ester skeletons in one molecule results in excellent polymerization initiation efficiency since two radicals are generated from one compound at the start of the polymerization reaction.
상기 한 분자내에 2개 이상의 광활성 옥심 에스테르 골격을 갖는 화합물은 하기 화학식 1로 표시되는 화합물이 R1 또는 R2를 통해 이량화된 것이 바람직하다.Preferably, the compound having two or more photoactive oxime ester skeletons in one molecule is dimerized through R 1 or R 2 .
[화학식 1][Formula 1]
Figure PCTKR2013008783-appb-I000019
Figure PCTKR2013008783-appb-I000019
(식 중, R1, R2 및 R3은 서로 독립적으로 R11, OR11, COR11, SR11, CONR12R13 또는 CN을 나타내고,Wherein R 1 , R 2 and R 3 independently of one another represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN,
R4 및 R5는 각각 독립적으로 R11, OR11, SR11, COR11, CONR12R13, NR12COR11, OCOR11, COOR11, SCOR11, OCSR11, COSR11, CSOR11, CN, 할로겐원자 또는 히드록시기를 나타내고,R 4 and R 5 are each independently R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN Represents a halogen atom or a hydroxy group,
a 및 b는 서로 독립적으로 0 내지 3인 정수이다.a and b are each independently an integer of 0 to 3.
R11, R12 및 R13은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며, 여기에서 알킬기, 아릴기, 아릴알킬기 및 복소환기의 수소원자는, 또한 R21, OR21, COR21, SR21, NR22R23, CON R22R23, -NR22-OR23, -NCOR22-OCOR23, -C(=N-OR21)-R22, -C(=N-OCOR21)-R22, CN, 할로겐원자, -CR21=CR22R23, -CO-CR21=CR22R23, OCO-CR21=CR22R23, O-C1-6알킬렌-OCOR21, COOR21, 에폭시기로 치환되어 있어도 되고, R 11 , R 12 and R 13 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Wherein the hydrogen atom of the alkyl group, aryl group, arylalkyl group and heterocyclic group is also R 21 , OR 21 , COR 21 , SR 21 , NR 22 R 23 , CON R 22 R 23 , -NR 22 -OR 23 , -NCOR 22 -OCOR 23 , -C (= N-OR 21 ) -R 22 , -C (= N-OCOR 21 ) -R 22 , CN, halogen atom, -CR 21 = CR 22 R 23 , -CO- CR 21 = CR 22 R 23 , OCO-CR 21 = CR 22 R 23 , OC 1-6 alkylene-OCOR 21 , COOR 21 , or may be substituted with an epoxy group,
R21, R22 및 R23은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며,R 21 , R 22 and R 23 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Indicates,
상기 R11, R12, R13, R21, R22 및 R23으로 표시되는 치환기의 알킬렌 부분의 메틸렌기는 불포화 결합, 에테르 결합, 티오에테르 결합, 에스테르 결합, 티오에스테르 결합, 아미드 결합 또는 우레탄 결합에 의해 1 내지 5회 중단되어 있어도 되고, 상기 치환기의 알킬 부분은 분기측쇄가 있어도 되고, 환상 알킬이어도 되며, 상기 치환기의 알킬 말단은 불포화 결합이어도 되고, 또한 R12와 R13및 R22와 R23은 각각 함께 환을 형성하고 있어도 되며, R3은 인접하는 벤젠환과 함께 환을 형성하고 있어도 된다.)The methylene group of the alkylene moiety of the substituent represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 is an unsaturated bond, ether bond, thioether bond, ester bond, thioester bond, amide bond or urethane It may be interrupted 1 to 5 times by a bond, the alkyl moiety of the substituent may have a branched chain, a cyclic alkyl, the alkyl terminal of the substituent may be an unsaturated bond, and R 12 , R 13 and R 22 and R 23 may each form a ring together, and R 3 may form a ring together with an adjacent benzene ring.)
바람직하게는 상기 화학식 1에서 R11, R12, R13, R21, R22 및 R23으로 표시되는 알킬기로서는, 예를 들면 메틸, 에틸, 프로필,이소프로필, 부틸, 이소부틸, s-부틸, t-부틸, 아밀, 이소아밀, t-아밀, 헥실, 헵틸, 옥틸, 이소 옥틸, 2-에틸헥실, t-옥틸, 노닐, 이소노닐, 데실, 이소데실, 운데실, 도데실, 테트라데실, 헥사데실, 옥타데실, 이코실, 시클로펜틸, 시클로헥실, 시클로헥실메틸, 비닐, 알릴, 부테닐, 에티닐, 프로피닐, 메톡시에틸, 에톡시에틸, 프로폭시에틸, 펜틸옥시에틸, 옥틸옥시에틸, 메톡시에톡시에틸, 에톡시에톡시에틸, 프로폭시에 톡시에틸, 메톡시프로필, 2-메톡시-1-메틸에틸 등을 들 수 있다. R11, R12, R13, R21, R22 및 R23으로 표시되는 아릴기로서는, 예를 들면 페닐, 톨릴, 크실릴, 에틸페닐, 클로로페닐, 나프틸, 안트릴, 페난트레닐, 상기 알킬기로 한 개 이상 치환된 페닐, 비페닐릴, 나프틸, 안트릴 등을 들 수 있다. R11, R12, R13, R21, R22 및 R23으로 표시되는 아릴알킬기로서는, 예를 들면 벤질, 클로로벤질, α-메틸벤질, α,α-디메틸벤질, 페닐에틸, 페닐에테닐 등을 들 수 있다. R11, R12, R13, R21, R22 및 R23으로 표시되는 복소환기로서는, 예를 들면 피리딜, 피리미딜, 푸릴, 티에닐, 테트라히드로푸릴, 디옥솔라닐, 벤조옥사졸-2-일, 테트라히드로피라닐, 피롤리딜, 이미다졸리딜, 피라졸리딜, 티아졸리딜, 이소티아졸리딜, 옥사졸리딜, 이소옥사졸리딜, 피페리딜, 피페라질, 모르폴리닐 등의 5 내지 7원 복소환이 바람직하게 예시된다. 또한 R12와 R13이 함께 형성할 수 있는 환, R22와 R23이 함께 형성할 수 있는 환, 및 R3이 인접하는 벤젠환과 함께 형성할 수 있는 환으로서는, 예를 들면 시클로펜탄환, 시클로헥산환, 시클로펜텐환, 벤젠환, 피페리딘환, 모르폴린환, 락톤환, 락탐환 등의 5 내지 7원 환을 들 수 있다. 또한 R11, R12, R13, R21, R22 및 R23을 치환해도 되는 할로겐원자 및 R4, R5로 표시되는 할로겐원자로서는 불소, 염소, 브롬, 요오드를 들 수 있다.Preferably, as the alkyl group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 in Chemical Formula 1, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl , t-butyl, amyl, isoamyl, t-amyl, hexyl, heptyl, octyl, isooctyl, 2-ethylhexyl, t-octyl, nonyl, isononyl, decyl, isodecyl, undecyl, dodecyl, tetradecyl , Hexadecyl, octadecyl, isocil, cyclopentyl, cyclohexyl, cyclohexylmethyl, vinyl, allyl, butenyl, ethynyl, propynyl, methoxyethyl, ethoxyethyl, propoxyethyl, pentyloxyethyl, octyl Oxyethyl, methoxyethoxyethyl, ethoxyethoxyethyl, propoxy oxyethyl, methoxypropyl, 2-methoxy-1-methylethyl and the like. As the aryl group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 , for example, phenyl, tolyl, xylyl, ethylphenyl, chlorophenyl, naphthyl, anthryl, phenanthrenyl, And phenyl, biphenylyl, naphthyl, anthryl and the like substituted with one or more of the above alkyl groups. Examples of the arylalkyl group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 include benzyl, chlorobenzyl, α-methylbenzyl, α, α-dimethylbenzyl, phenylethyl and phenylethenyl Etc. can be mentioned. As the heterocyclic group represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 , for example, pyridyl, pyrimidyl, furyl, thienyl, tetrahydrofuryl, dioxolanyl, benzoxazole- 2-yl, tetrahydropyranyl, pyrrolidyl, imidazolidil, pyrazolidyl, thiazolidyl, isothiazolidil, oxazolidyl, isoxazolidyl, piperidyl, piperazil, morpholinyl 5-7 membered heterocycles, such as these, are illustrated preferably. As also ring which may be formed with a ring of benzene which R 12 and R 13 rings, which can be formed with R 22 and R 23 the ring, and R 3 which can form with the adjacent, for example, a cyclopentyl bullet, 5-7 membered rings, such as a cyclohexane ring, a cyclopentene ring, a benzene ring, a piperidine ring, a morpholine ring, a lactone ring, and a lactam ring, are mentioned. Examples of the halogen atom that may be substituted for R 11 , R 12 , R 13 , R 21 , R 22 and R 23 and the halogen atom represented by R 4 , R 5 include fluorine, chlorine, bromine and iodine.
상기 치환기의 알킬렌 부분의 메틸렌기는 불포화 결합, 에테르 결합, 티오에테르 결합, 에스테르 결합, 티오에스테르 결합, 아미드 결합 또는 우레탄 결합에 의해 1 내지 5회 중단되어 있어도 되고, 이때 중단하는 결합기는 1종 또는 2종 이상의 기여도 되고, 연속하여 중단할 수 있는 기인 경우는 2개 이상 연속하여 중단해도 된다. 또한 상기 치환기의 알킬 부분은 분기측쇄가 있어도 되고, 환상 알킬이어도 되며, 상기 치환기의 알킬 말단은 불포화 결합이어도 된다.The methylene group of the alkylene moiety of the substituent may be interrupted 1 to 5 times by an unsaturated bond, an ether bond, a thioether bond, an ester bond, a thioester bond, an amide bond or a urethane bond, and at this time, one or more bond groups are interrupted Two or more types of contribution may also be sufficient, and when it is the group which can be interrupted continuously, you may interrupt 2 or more consecutively. In addition, the alkyl part of the said substituent may have a branched side chain, cyclic alkyl may be sufficient, and the alkyl terminal of the said substituent may be an unsaturated bond.
본 발명의 옥심에스테르화합물 중에서도, 상기 화학식 1에 있어서, R1이 탄소원자수 11 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기, 탄소원자수 2 내지 20인 복소환기, OR11, COR11, SR11, CONR12R13 또는 CN인 것이나, R3이 에테르 결합 또는 에스테르 결합으로 1 내지 5회 중단되어 있는 탄소원자수 1 내지 12인 알킬기, 탄소원자수 13 내지 20인 알킬기, OR11, COR11, SR11, CONR12R13 또는 CN인 것, 특히 R1이 탄소원자수 11 내지 20인 알킬기 또는 탄소원자수 6 내지 30인 아릴기인 것, 혹은 R3이 알킬기의 알킬렌 부분의 메틸렌기가 에테르 결합 또는 에스테르 결합으로 1 내지 5회 중단되어도 되는 탄소원자수 8 이상의 분기 알킬기인 것; 알킬기의 알킬렌 부분의 메틸렌기가 에테르 결합 또는 에스테르 결합으로 1 내지 5회 중단되어 있어도 되는 소원자수 13 이상의 알킬기인 것; R3이 에테르 결합에 의해 1 내지 5회 중단되어 있는 알킬기인 것; R3이 에스테르 결합에 의해 1 내지 5회 중단되어 있는 알킬기인 것이 합성이 용이하며, 또한 광중합 개시제로서 사용한 경우, 용매인 프로필렌글리콜-1-노메틸에테르-2-아세테이트 또는 시클로헥사논에 1질량%이상 용해되어 광중합 개시제로서의 요구를 만족하므로 바람직하다.Among the oxime ester compounds of the present invention, in Formula 1, R 1 is an alkyl group having 11 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms, and a complex having 2 to 20 carbon atoms. Ventilation, OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN, but R 3 is an alkyl group having 1 to 12 carbon atoms interrupted 1 to 5 times by ether or ester bond, 13 to 20 carbon atoms An alkyl group, OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN, in particular R 1 is an alkyl group having 11 to 20 carbon atoms or an aryl group having 6 to 30 carbon atoms, or R 3 is an alkylene of an alkyl group The methylene group of the moiety is a branched alkyl group having 8 or more carbon atoms which may be interrupted 1 to 5 times by an ether bond or ester bond; The methylene group of the alkylene portion of the alkyl group is an alkyl group of 13 or more small atoms which may be interrupted 1 to 5 times by an ether bond or ester bond; R 3 is an alkyl group interrupted 1 to 5 times by an ether bond; It is easy to synthesize | combine that R <3> is the alkyl group interrupted 1-5 times by the ester bond, and when used as a photoinitiator, it is 1 mass in the solvent propylene glycol-1-nomethylether-2-acetate or cyclohexanone. It is preferable because it dissolves in at least% and satisfies the requirements as a photopolymerization initiator.
본 발명의 옥심에스테르화합물은 하기 화학식 2 및 화학식 3에 나타낸 바와 같이, 화학식 1로 표시되는 화합물이 R1또는 R2를 통해 이량화된 것이 바람직하다. In the oxime ester compound of the present invention, as shown in the following Chemical Formula 2 and Chemical Formula 3, the compound represented by Chemical Formula 1 is preferably dimerized through R 1 or R 2 .
[화학식 2][Formula 2]
Figure PCTKR2013008783-appb-I000020
Figure PCTKR2013008783-appb-I000020
[화학식 3][Formula 3]
Figure PCTKR2013008783-appb-I000021
Figure PCTKR2013008783-appb-I000021
(식 중, R1 내지 R5는 상기 화학식 1에서 정의된 바와 같음)Wherein R 1 to R 5 are as defined in Formula 1 above.
상기 화학식 1로 표시되는 본 발명의 옥심 에스테르 화합물의 바람직한 구체예로서는 하기의 화학식 4 내지 10의 화합물을 들 수 있으나, 이에 한정되는 것은 아니다.Preferred specific examples of the oxime ester compound of the present invention represented by Formula 1 include, but are not limited to, the compounds of Formulas 4 to 10 shown below.
[화학식 4][Formula 4]
Figure PCTKR2013008783-appb-I000022
Figure PCTKR2013008783-appb-I000022
[화학식 5][Formula 5]
Figure PCTKR2013008783-appb-I000023
Figure PCTKR2013008783-appb-I000023
[화학식 6][Formula 6]
Figure PCTKR2013008783-appb-I000024
Figure PCTKR2013008783-appb-I000024
[화학식 7][Formula 7]
Figure PCTKR2013008783-appb-I000025
Figure PCTKR2013008783-appb-I000025
[화학식 8][Formula 8]
Figure PCTKR2013008783-appb-I000026
Figure PCTKR2013008783-appb-I000026
[화학식 9][Formula 9]
Figure PCTKR2013008783-appb-I000027
Figure PCTKR2013008783-appb-I000027
[화학식 10][Formula 10]
Figure PCTKR2013008783-appb-I000028
Figure PCTKR2013008783-appb-I000028
상기 화학식 3으로 표시되는 본 발명의 옥심 에스테르 화합물의 바람직한 구체예로서는 하기의 화학식 11의 화합물을 들 수 있다. 단 본 발명은 이하의 화합물에 의해 하등 제한을 받는 것은 아니다.As a preferable specific example of the oxime ester compound of this invention represented by said Formula (3), the compound of following formula (11) is mentioned. However, this invention is not restrict | limited at all by the following compounds.
[화학식 11][Formula 11]
Figure PCTKR2013008783-appb-I000029
Figure PCTKR2013008783-appb-I000029
상기 한 분자내에 2개 이상의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 본 발명의 경화성 수지 조성물 총 중량에 대하여 0.1 내지 40중량%로 포함될 수 있다. 바람직하게는 1 내지 30중량%로 포함될수 있다 .상기 함량 범위로 포함되면 광에 대한 높은 감도를 나타내어 저노광량에서도 중합 반응이 충분히 진행되어 층간 접착성이 우수해지므로 바람직하다.The photopolymerization initiator having two or more photoactive oxime ester skeletons in one molecule may be included in an amount of 0.1 to 40% by weight based on the total weight of the curable resin composition of the present invention. Preferably, it may be included in an amount of 1 to 30% by weight. When included in the above content range, it exhibits high sensitivity to light, and thus the polymerization reaction proceeds sufficiently even at a low exposure amount, so that the interlayer adhesion is excellent.
본 발명의 경화성 수지 조성물에 함유되는 광중합 개시제는 상기 한 분자내에 2개 이상의 광활성 옥심 에스테르 골격을 갖는 화합물 이외에, 제한되지 않으나 트리아진계 화합물, 아세토페논계 화합물, 비이미다졸계 화합물 및 옥심 화합물로 이루어지는 군으로부터 선택되는 1종 이상의 화합물을 함께 사용할 수 있다. 상기 광중합 개시제를 함유하는 경화성 수지 조성물은 고감도이고, 이 조성물을 사용하여 형성되는 막은 강도나 표면 평활성이 양호해진다.The photopolymerization initiator contained in the curable resin composition of the present invention includes, but is not limited to, a triazine-based compound, an acetophenone-based compound, a biimidazole-based compound, and an oxime compound, in addition to the compound having two or more photoactive oxime ester skeletons in one molecule. One or more compounds selected from the group can be used together. Curable resin composition containing the said photoinitiator is highly sensitive, and the film | membrane formed using this composition becomes favorable in strength and surface smoothness.
상기 트리아진계 화합물로서는, 예를 들면 2,4-비스(트리클로로메틸)-6-(4-메톡시페닐)-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-(4-메톡시나프틸)-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-피페로닐-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-(4-메톡시스티릴)-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(5-메틸퓨란-2-일)에테닐]-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(퓨란-2-일)에테닐]-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(4-디에틸아미노-2-메틸페닐)에테닐]-1,3,5-트리아진, 2,4-비스(트리클로로메틸)-6-[2-(3,4-디메톡시페닐)에테닐]-1,3,5-트리아진 등을 들 수 있다.As said triazine type compound, it is 2, 4-bis (trichloromethyl) -6- (4-methoxyphenyl) -1, 3, 5- triazine, 2, 4-bis (trichloromethyl)-, for example. 6- (4-methoxynaphthyl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6-piperonyl-1,3,5-triazine, 2,4- Bis (trichloromethyl) -6- (4-methoxystyryl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (5-methylfuran-2 -Yl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloromethyl) -6- [2- (furan-2-yl) ethenyl] -1,3,5-tri Azine, 2,4-bis (trichloromethyl) -6- [2- (4-diethylamino-2-methylphenyl) ethenyl] -1,3,5-triazine, 2,4-bis (trichloro Methyl) -6- [2- (3,4-dimethoxyphenyl) ethenyl] -1,3,5-triazine and the like.
또한 상기 아세토페논계 화합물로서는, 예를 들면, 디에톡시아세토페논, 2-히드록시-2-메틸-1-페닐프로판-1-온, 벤질디메틸케탈, 2-히드록시-1-[4-(2-히드록시에톡시)페닐]-2-메틸프로판-1-온, 1-히드록시시클로헥실페닐케톤, 2-메틸-1-(4-메틸티오페닐)-2-모르폴리노프로판-1-온, 2-벤질-2-디메틸아미노-1-(4-모르폴리노페닐)부탄-1-온, 2-히드록시-2-메틸-1-[4-(1-메틸비닐)페닐]프로판-1-온의 올리고머 등을 들 수 있다.Moreover, as said acetophenone type compound, for example, diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl dimethyl ketal, 2-hydroxy-1- [4- ( 2-hydroxyethoxy) phenyl] -2-methylpropane-1-one, 1-hydroxycyclohexylphenyl ketone, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1 -One, 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) butan-1-one, 2-hydroxy-2-methyl-1- [4- (1-methylvinyl) phenyl] And oligomers of propane-1-one.
또한 상기 열거한 아세토페논계 화합물이외에 사용가능한 아세토페논계 화합물로서는, 예를 들면 하기 화학식 12로 표시되는 화합물을 들 수 있다.Moreover, as an acetophenone type compound which can be used other than the acetophenone type compound enumerated above, the compound represented by following formula (12) is mentioned, for example.
[화학식 12][Formula 12]
Figure PCTKR2013008783-appb-I000030
Figure PCTKR2013008783-appb-I000030
상기 화학식 12에서, R1 내지 R4는 서로 독립적으로 수소 원자, 할로겐 원자, 수산기, 탄소수 1 내지 12의 알킬기, 탄소수 1 내지 12의 알킬기에 의해 치환될 수도 있는 페닐기, 탄소수 1 내지 12의 알킬기에 의해 치환될 수도 있는 벤질기 또는 탄소수 1 내지 12의 알킬기에 의해 치환될 수도 있는 나프틸기를 나타낸다.In Formula 12, R 1 to R 4 are independently a hydrogen atom, a halogen atom, a hydroxyl group, a phenyl group which may be substituted by an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms, an alkyl group having 1 to 12 carbon atoms The naphthyl group which may be substituted by the benzyl group or C1-C12 alkyl group which may be substituted by this is shown.
상기 화학식 12로 표시되는 화합물의 구체예로는 2-메틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-프로필-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-부틸-2-아미노(4-모르폴리노페닐)에탄-1-온, 2-메틸-2-아미노(4-모르폴리노페닐)프로판-1-온, 2-메틸-2-아미노(4-모르폴리노페닐)부탄-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)프로판-1-온, 2-에틸-2-아미노(4-모르폴리노페닐)부탄-1-온, 2-메틸-2-메틸아미노(4-모르폴리노페닐)프로판-1-온, 2-메틸-2-디메틸아미노(4-모르폴리노페닐)프로판-1-온, 2-메틸-2-디에틸아미노(4-모르폴리노페닐)프로판-1-온 등을 들 수 있다.Specific examples of the compound represented by Formula 12 include 2-methyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-ethyl-2-amino (4-morpholinophenyl) ethane- 1-one, 2-propyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-butyl-2-amino (4-morpholinophenyl) ethan-1-one, 2-methyl- 2-amino (4-morpholinophenyl) propane-1-one, 2-methyl-2-amino (4-morpholinophenyl) butan-1-one, 2-ethyl-2-amino (4-morpholin Nophenyl) propane-1-one, 2-ethyl-2-amino (4-morpholinophenyl) butan-1-one, 2-methyl-2-methylamino (4-morpholinophenyl) propane-1- On, 2-methyl-2-dimethylamino (4-morpholinophenyl) propan-1-one, 2-methyl-2-diethylamino (4-morpholinophenyl) propan-1-one, etc. may be mentioned. have.
상기 비이미다졸 화합물로서는, 예를 들면 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라페닐비이미다졸, 2,2'-비스(2,3-디클로로페닐)-4,4',5,5'-테트라페닐비이미다졸, 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라(알콕시페닐)비이미다졸, 2,2'-비스(2-클로로페닐)-4,4',5,5'-테트라 (트리알콕시페닐)비이미다졸 또는 4,4',5,5' 위치의 페닐기가 카르보알콕시기에 의해 치환되어 있는 이미다졸 화합물 등을 들 수 있다. 이들 중에서 2,2'비스(2-클로로페닐)-4,4',5,5'-테트라페닐비이미다졸 또는 2,2'-비스(2,3-디클로로페닐)-4,4',5,5'-테트라페닐비이미다졸이 바람직하게 사용된다.As said biimidazole compound, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'- tetraphenyl biimidazole, 2,2'-bis (2,3-, for example) Dichlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole, 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetra (alkoxyphenyl) biimi Dazole, 2,2'-bis (2-chlorophenyl) -4,4 ', 5,5'-tetra (trialkoxyphenyl) biimidazole or a phenyl group at the 4,4', 5,5 'position The imidazole compound substituted with the alkoxy group etc. are mentioned. Among them, 2,2'bis (2-chlorophenyl) -4,4 ', 5,5'-tetraphenylbiimidazole or 2,2'-bis (2,3-dichlorophenyl) -4,4', 5,5'-tetraphenylbiimidazole is preferably used.
상기 옥심 화합물로는, 0-에톡시카르보닐-α-옥시이미노-1-페닐프로판-1-온과, 하기의 화학식 13 내지 15로 표시되는 화합물 등을 들 수 있다.Examples of the oxime compound include 0-ethoxycarbonyl-α-oxyimino-1-phenylpropan-1-one and the compounds represented by the following formulas (13) to (15).
[화학식 13][Formula 13]
Figure PCTKR2013008783-appb-I000031
Figure PCTKR2013008783-appb-I000031
[화학식 14][Formula 14]
Figure PCTKR2013008783-appb-I000032
Figure PCTKR2013008783-appb-I000032
[화학식 15][Formula 15]
Figure PCTKR2013008783-appb-I000033
Figure PCTKR2013008783-appb-I000033
또한, 본 발명의 범위를 벗어나지 않는 한도 내에서 이 분야에서 통상 사용되고 있는 그 밖의 광중합 개시제 등을 추가로 병용할 수도 있다. 그 밖의 광중합 개시제로서는, 예를 들면 벤조인계 화합물, 벤조페논계 화합물, 티오 크산톤계 화합물, 안트라센계 화합물 등을 들 수 있다. 이들은 각각 단독으로 또는 2종 이상 조합하여 사용할 수 있다.Moreover, the other photoinitiator etc. which are normally used in this field can also be used together, without departing from the scope of the present invention. As another photoinitiator, a benzoin compound, a benzophenone type compound, a thioxanthone type compound, an anthracene type compound etc. are mentioned, for example. These can be used individually or in combination of 2 or more types, respectively.
상기 벤조인계 화합물로서는, 예를 들면, 벤조인, 벤조인메틸에테르, 벤조인에틸에테르, 벤조인이소프로필에테르, 벤조인이소부틸에테르 등을 들 수 있다.As said benzoin type compound, benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin isobutyl ether, etc. are mentioned, for example.
상기 벤조페논계 화합물로서는, 예를 들면 벤조페논, 0-벤조일벤조산메틸, 4-페닐벤조페논, 4-벤조일-4'-메틸디페닐술피드, 3,3',4,4'-테트라(tert-부틸퍼옥시카르보닐)벤조페논, 2,4,6-트리메틸벤조페논 등을 들 수 있다.As said benzophenone type compound, for example, benzophenone, methyl 0- benzoyl benzoate, 4-phenyl benzophenone, 4-benzoyl-4'- methyl diphenyl sulfide, 3, 3 ', 4, 4'- tetra ( tert-butylperoxycarbonyl) benzophenone, 2,4,6-trimethylbenzophenone, etc. are mentioned.
상기 티오크산톤계 화합물로서는, 예를 들면 2-이소프로필티오크산톤, 2,4-디에틸티오크산톤, 2,4-디클로로티오 크산톤, 1-클로로-4-프로폭시티오크산톤 등을 들 수 있다.As said thioxanthone type compound, 2-isopropyl thioxanthone, 2, 4- diethyl thioxanthone, 2, 4- dichloro thioxanthone, 1-chloro-4- propoxy thioxanthone, etc. are mentioned, for example. Can be mentioned.
상기 안트라센계 화합물로서는, 예를 들면 9,10-디메톡시안트라센, 2-에틸-9,10-디메톡시안트라센, 9,10-디에톡시안트라센, 2-에틸-9,10-디에톡시안트라센 등을 들 수 있다.Examples of the anthracene-based compound include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, and the like. Can be mentioned.
그 밖에 2,4,6-트리메틸벤조일디페닐포스핀옥시드, 10-부틸-2-클로로아크리돈, 2-에틸안트라퀴논, 9,10- 페난트렌퀴논, 캄포퀴논, 페닐클리옥실산메틸, 티타노센 화합물 등을 그 밖의 광중합 개시제로서 들 수 있다.Others include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 10-butyl-2-chloroacridone, 2-ethylanthraquinone, 9,10-phenanthrenequinone, camphorquinone, methyl phenyloxyoxylate, A titanocene compound etc. are mentioned as another photoinitiator.
또한, 광중합 개시제에는 광중합 개시 보조제를 조합하여 사용할 수도 있다. 광중합 개시제에 광중합 개시 보조제를 병용하면, 이들을 함유하는 경화성 수지 조성물은 더욱 고감도가 되어 이 조성물을 사용하여 수지층을 형성할 때의 생산성이 향상되므로 바람직하다.In addition, you may use combining a photoinitiator with a photoinitiator. When a photoinitiator adjuvant is used together with a photoinitiator, since curable resin composition containing these is more sensitive and productivity at the time of forming a resin layer using this composition is preferable, it is preferable.
광중합 개시 보조제로서는 아민 화합물, 카르복실산 화합물이 바람직하게 사용된다.As the photopolymerization initiation aid, an amine compound and a carboxylic acid compound are preferably used.
광중합 개시 보조제 중 아민 화합물의 구체예로서는 트리에탄올아민, 메틸디에탄올아민, 트리이소프로판올 아민 등의 지방족 아민 화합물, 4-디메틸아미노벤조산메틸, 4-디메틸아미노벤조산에틸, 4-디메틸아미노벤조산이 소아밀, 4-디메틸아미노벤조산2-에틸헥실, 벤조산2-디메틸아미노에틸, N,N-디메틸파라톨루이딘, 4,4'-비스(디메 틸아미노)벤조페논(통칭 : 미힐러 케톤), 4,4'-비스(디에틸아미노)벤조페논 등의 방향족 아민 화합물을 들 수 있다. 아민 화합물로서는 방향족 아민 화합물이 바람직하게 사용된다.Specific examples of the amine compound in the photopolymerization initiation aid include aliphatic amine compounds such as triethanolamine, methyldiethanolamine, and triisopropanol amine, 4-dimethylaminobenzoate methyl, 4-dimethylaminobenzoate ethyl, 4-dimethylaminobenzoic acid, and pediatric wheat. -Dimethylaminobenzoic acid 2-ethylhexyl, benzoic acid 2-dimethylaminoethyl, N, N-dimethyl paratoluidine, 4,4'-bis (dimethylamino) benzophenone (common name: Michler's ketone), 4,4'- Aromatic amine compounds, such as bis (diethylamino) benzophenone, are mentioned. As an amine compound, an aromatic amine compound is used preferably.
카르복실산 화합물의 구체예로서는 페닐티오아세트산, 메틸페닐티오아세트산, 에틸페닐티오아세트산, 메틸에틸 페닐티오아세트산, 디메틸페닐티오아세트산, 메톡시페닐티오아세트산, 디메톡시페닐티오아세트산, 클로로페닐티 오아세트산, 디클로로페닐티오아세트산, N-페닐글리신, 페녹시아세트산, 나프틸티오아세트산, N-나프틸글리신, 나프톡시아세트산 등의 방향족 헤테로아세트산류를 들 수 있다. 광중합 개시 보조제의 함량은 경화성 수지 조성물 총 중량에 대하여 통상 0.1 내지 40중량%일 수 있다. 바람직하게는 0.5 내지 30중량% 로 포함될수 있다Specific examples of the carboxylic acid compound include phenylthioacetic acid, methylphenylthioacetic acid, ethylphenylthioacetic acid, methylethyl phenylthioacetic acid, dimethylphenylthioacetic acid, methoxyphenylthioacetic acid, dimethoxyphenylthioacetic acid, chlorophenylthioacetic acid, dichloro And aromatic heteroacetic acids such as phenylthioacetic acid, N-phenylglycine, phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, and naphthoxyacetic acid. The content of the photopolymerization initiation aid may be usually 0.1 to 40% by weight based on the total weight of the curable resin composition. Preferably it may be included in 0.5 to 30% by weight.
광중합 개시 보조제의 함량이 상기의 범위인 경우에는 경화성 수지 조성물의 감도가 더 높아지고, 이 조성물을 사용하여 형성되는 수지층의 형성이 보다 빠르게 되기 때문에 바람직하다.When the content of the photopolymerization initiation aid is in the above range, the sensitivity of the curable resin composition is higher, and thus the formation of the resin layer formed by using the composition is preferable.
본 발명에 따른 제1 단량체는 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 것을 특징으로 한다. 제1 단량체는 (메타)아크릴레이트기가 광경화 반응에 참여하며, 이소시아네이트기가 열경화 반응에 참여한다. (메타)아크릴레이트기는 다른 분자의 탄소-탄소 이중결합과 반응하여 탄소-탄소 포화 결합을 형성하며, 이소시아네이트기는 제2 단량체의 히드록시기 또는 카르복시기와 반응하여 우레탄 결합을 형성한다.The first monomer according to the present invention is characterized by including an isocyanate group and a (meth) acrylate group at its terminals to enable photocuring and thermosetting. In the first monomer, the (meth) acrylate group participates in the photocuring reaction, and the isocyanate group participates in the thermosetting reaction. (Meth) acrylate groups react with carbon-carbon double bonds of other molecules to form carbon-carbon saturated bonds, and isocyanate groups react with hydroxyl or carboxyl groups of the second monomer to form urethane bonds.
제1 단량체의 이소시아네이트기는 광학 필름의 제조 공정에서 수행되는 통상적인 건조 단계의 온도인 약 80 내지 130℃의 온도에서 히드록시기 또는 카르복시기와 반응한다(열경화).The isocyanate group of the first monomer is reacted with a hydroxyl group or a carboxyl group at a temperature of about 80 to 130 ° C., which is the temperature of a typical drying step carried out in the process of producing an optical film (thermosetting).
이와 같이, 제1 단량체는 제2 단량체와 가교되므로 수지층의 경도 및 접착력을 강화시킬 수 있다.As such, since the first monomer is crosslinked with the second monomer, the hardness and the adhesion of the resin layer can be enhanced.
또한, 제1 단량체의 (메타)아크릴레이트기는 수지층이 접촉하는 기재 필름이 PMMA로 제조되는 경우에, PMMA의 표면에 잔류하는 미반응 탄소-탄소 불포화 결합 반응성기와 반응하여 탄소-탄소 포화 결합을 형성할 수도 있다. 이 경우, 수지층과 기재 필름은 화학적 결합으로 연결되어 더욱 강한 층간 접착력을 가질 수 있다.In addition, the (meth) acrylate group of the first monomer reacts with the unreacted carbon-carbon unsaturated bond reactive group remaining on the surface of the PMMA when the base film to which the resin layer is in contact is made of PMMA to form a carbon-carbon saturated bond. It may be formed. In this case, the resin layer and the base film may be connected by chemical bonding to have a stronger interlayer adhesion.
본 발명에 따른 제1 단량체의 예로는 하기 화학식 16 내지 19의 화합물로 이루어진 군에서 선택된 적어도 1종을 들 수 있다.Examples of the first monomer according to the present invention include at least one selected from the group consisting of compounds represented by the following Chemical Formulas 16 to 19.
[화학식 16][Formula 16]
Figure PCTKR2013008783-appb-I000034
Figure PCTKR2013008783-appb-I000034
(식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
[화학식 17][Formula 17]
Figure PCTKR2013008783-appb-I000035
Figure PCTKR2013008783-appb-I000035
(식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
R10는 (a)
Figure PCTKR2013008783-appb-I000036
또는 (b)
Figure PCTKR2013008783-appb-I000037
이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
R 10 is (a)
Figure PCTKR2013008783-appb-I000036
Or (b)
Figure PCTKR2013008783-appb-I000037
E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
[화학식 18][Formula 18]
Figure PCTKR2013008783-appb-I000038
Figure PCTKR2013008783-appb-I000038
(식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
[화학식 19][Formula 19]
Figure PCTKR2013008783-appb-I000039
Figure PCTKR2013008783-appb-I000039
(식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
본 발명의 경화성 수지 조성물에 있어서, 위 화학식 16 내지 화학식 19로 표시되는 제1 단량체는 보다 우수한 층간 접착력을 확보하기 위해 화학식 17 내지 화학식 19로 표시되는 화합물 중 적어도 하나와 위 화학식 16으로 표시되는 화합물의 혼합물로 사용될 수 있다.In the curable resin composition of the present invention, the first monomer represented by the above formulas (16) to (19) is at least one of the compounds represented by the formulas (17) to (19) and the compound represented by the formula (16) in order to ensure better interlayer adhesion It can be used as a mixture of.
위 화학식 16 내지 화학식 19의 제1 단량체의 보다 구체적인 예시는 하기 화학식 20 내지 화학식 30으로 표시되는 화합물로 이루어진 군에서 선택된 1종 이상인 것을 들 수 있다:More specific examples of the first monomer of Formula 16 to Formula 19 may include at least one selected from the group consisting of compounds represented by Formula 20 to Formula 30:
[화학식 20][Formula 20]
Figure PCTKR2013008783-appb-I000040
Figure PCTKR2013008783-appb-I000040
[화학식 21][Formula 21]
Figure PCTKR2013008783-appb-I000041
Figure PCTKR2013008783-appb-I000041
[화학식 22][Formula 22]
Figure PCTKR2013008783-appb-I000042
Figure PCTKR2013008783-appb-I000042
[화학식 23][Formula 23]
Figure PCTKR2013008783-appb-I000043
Figure PCTKR2013008783-appb-I000043
[화학식 24][Formula 24]
Figure PCTKR2013008783-appb-I000044
Figure PCTKR2013008783-appb-I000044
[화학식 25][Formula 25]
Figure PCTKR2013008783-appb-I000045
Figure PCTKR2013008783-appb-I000045
[화학식 26][Formula 26]
Figure PCTKR2013008783-appb-I000046
Figure PCTKR2013008783-appb-I000046
[화학식 27][Formula 27]
Figure PCTKR2013008783-appb-I000047
Figure PCTKR2013008783-appb-I000047
[화학식 28][Formula 28]
Figure PCTKR2013008783-appb-I000048
Figure PCTKR2013008783-appb-I000048
[화학식 29][Formula 29]
Figure PCTKR2013008783-appb-I000049
Figure PCTKR2013008783-appb-I000049
[화학식 30][Formula 30]
Figure PCTKR2013008783-appb-I000050
Figure PCTKR2013008783-appb-I000050
위 화학식 19로 표시되는 화합물 및 그 화합물의 예시인 위 화학식 27, 화학식 28, 화학식 29 및 화학식 30로 표시되는 화합물은 말단의 디메틸 피라졸기가 건조 공정 등의 열처리 과정을 통해 분리되고, 그에 따라 말단에 이소시아네이트기를 갖게 된다.Compounds represented by the above formula (19) and compounds represented by the above formula 27, 28, 29 and 30, which is an example of the compound is the terminal dimethyl pyrazole group is separated through a heat treatment process, such as drying process, and thus It will have an isocyanate group.
본 발명에 따른 제1 단량체는 조성물 총 중량에 대하여 5 내지 90중량%, 바람직하게는 10 내지 70중량%로 포함되는 것이 바람직하다. 위 범위에서 충분한 접착력을 확보할 수 있으며, 지나치게 과량으로 첨가되면 접착력은 개선되지만 광학필름에 적용시 다른 물성이 저하될 수 있다.The first monomer according to the present invention is preferably included in 5 to 90% by weight, preferably 10 to 70% by weight relative to the total weight of the composition. It is possible to secure sufficient adhesive strength in the above range, when excessively added, the adhesive strength is improved, but when applied to the optical film, other physical properties may be lowered.
본 발명의 경화성 수지층 형성용 조성물은 열경화를 촉진하기 위해 열중합 개시제 더 포함할 수 있다. 본 발명에서 사용 가능한 열중합 개시제는 당분야에서 사용되는 것이라면 특별한 제한없이 사용할 수 있다. The composition for forming a curable resin layer of the present invention may further include a thermal polymerization initiator to promote thermal curing. The thermal polymerization initiator usable in the present invention can be used without particular limitation as long as it is used in the art.
본 발명에 따른 제2 단량체는 히드록시기 또는 카르복시기를 갖는 다관능 단량체인 것을 특징으로 한다. 제2 단량체는 전술한 바와 같이, 히드록시기 또는 카르복시기를 통해 가교 반응을 수행하며, 필요에 따라 관능기로서 탄소-탄소 불포화 결합을 갖는 경우에는 중합 반응도 수행할 수 있다.The second monomer according to the invention is characterized in that the polyfunctional monomer having a hydroxy group or a carboxyl group. As described above, the second monomer performs a crosslinking reaction through a hydroxy group or a carboxyl group, and, if necessary, also has a carbon-carbon unsaturated bond as a functional group, and may also perform a polymerization reaction.
제2 단량체의 구체적인 예를 들면 하기 화학식 31로 표시되는 화합물을 들 수 있다.As a specific example of a 2nd monomer, the compound represented by following General formula (31) is mentioned.
[화학식 31][Formula 31]
Figure PCTKR2013008783-appb-I000051
Figure PCTKR2013008783-appb-I000051
(식 중, R1, R2, R3 및 R4 중 적어도 하나는 수소 또는 카르복시기이고 나머지는 서로 독립적으로 메틸기 또는 아크릴로일기에서 선택되며, A는
Figure PCTKR2013008783-appb-I000052
,
Figure PCTKR2013008783-appb-I000053
,
Figure PCTKR2013008783-appb-I000054
,
Figure PCTKR2013008783-appb-I000055
,
Figure PCTKR2013008783-appb-I000056
또는
Figure PCTKR2013008783-appb-I000057
에서 선택되며, a는 1 내지 3의 정수이고, b는 0 내지 12의 정수임).
Wherein at least one of R 1 , R 2 , R 3 and R 4 is hydrogen or a carboxy group and the rest are independently selected from methyl or acryloyl groups, and A is
Figure PCTKR2013008783-appb-I000052
,
Figure PCTKR2013008783-appb-I000053
,
Figure PCTKR2013008783-appb-I000054
,
Figure PCTKR2013008783-appb-I000055
,
Figure PCTKR2013008783-appb-I000056
or
Figure PCTKR2013008783-appb-I000057
Is a integer of 1 to 3, b is an integer of 0 to 12).
상기 화학식 31의 화합물의 보다 구체적인 예시는 하기 화학식 32 내지 화학식 39의 화합물을 들 수 있으나, 이에 한정되는 것은 아니다.More specific examples of the compound represented by Chemical Formula 31 may include a compound represented by Chemical Formula 32 to Chemical Formula 39, but are not limited thereto.
[화학식 32][Formula 32]
Figure PCTKR2013008783-appb-I000058
Figure PCTKR2013008783-appb-I000058
[화학식 33][Formula 33]
Figure PCTKR2013008783-appb-I000059
Figure PCTKR2013008783-appb-I000059
[화학식 34][Formula 34]
Figure PCTKR2013008783-appb-I000060
Figure PCTKR2013008783-appb-I000060
[화학식 35][Formula 35]
Figure PCTKR2013008783-appb-I000061
Figure PCTKR2013008783-appb-I000061
[화학식 36][Formula 36]
Figure PCTKR2013008783-appb-I000062
Figure PCTKR2013008783-appb-I000062
[화학식 37][Formula 37]
Figure PCTKR2013008783-appb-I000063
Figure PCTKR2013008783-appb-I000063
[화학식 38][Formula 38]
Figure PCTKR2013008783-appb-I000064
Figure PCTKR2013008783-appb-I000064
[화학식 39][Formula 39]
Figure PCTKR2013008783-appb-I000065
Figure PCTKR2013008783-appb-I000065
본 발명에 따른 제2 단량체는 폴리스티렌 환산의 중량평균 분자량이 200 내지 3,000인 것이 바람직하며, 보다 바람직하게는 500 내지 1,000일 수 있다. 제2 단량체의 중량평균 분자량이 3,000을 초과하면 분산성이 저하되거나, 안정한 분산체를 얻지 못하여 광학 필름의 휘도가 저하될 수 있으며, 분자량이 200미만이면 광학 필름의 휘도가 저하될 수 있다.It is preferable that the weight average molecular weight of polystyrene conversion of the 2nd monomer which concerns on this invention is 200-3,000, More preferably, it may be 500-1,000. If the weight average molecular weight of the second monomer exceeds 3,000, the dispersibility may be reduced, or the brightness of the optical film may be lowered because a stable dispersion is not obtained. If the molecular weight is less than 200, the brightness of the optical film may be lowered.
본 발명에 따른 제2 단량체는 조성물 총 중량에 대하여 5 내지 60중량%로 포함되는 것이 바람직하다. 함량이 5중량% 미만이면 경화도가 저하될 수 있으며, 60중량% 초과이면 열경화에 불리할수있다 The second monomer according to the invention is preferably included in 5 to 60% by weight relative to the total weight of the composition. If the content is less than 5% by weight, the degree of curing may be lowered, and if it is more than 60% by weight, it may be detrimental to heat curing.
바람직하게는, 본 발명에 따른 제1 단량체와 제2 단량체의 혼합 중량비는 제1 단량체:제2 단량체 = 1:1-2일 수 있으며, 이 범위에서 본 발명의 효과를 보다 극대화할 수 있다.Preferably, the mixing weight ratio of the first monomer and the second monomer according to the present invention may be the first monomer: the second monomer = 1: 1-2, in this range it can be more maximized the effect of the present invention.
본 발명의 경화성 수지 조성물은 상기 성분들을 용해시킬 수 있는 유기 용매를 포함한다. 유기 용매는 성분들의 용해 및 적절한 점도를 유지하여 조성물이 바람직한 코팅성, 가공성 등을 나타내도록 한다.Curable resin composition of this invention contains the organic solvent which can melt | dissolve the said components. The organic solvent maintains the dissolution and proper viscosity of the components so that the composition exhibits the desired coating properties, processability, and the like.
이러한 유기 용매의 예로는 상기 성분들을 용해시킬 수 있는 성분을 적절하게 사용할 수 있으나, 바람직하게는 산소 원자를 포함하는 용매로서, 하기 수학식 1로 표시되는 SPDS값이 1 이하인 용매와 15 이상인 용매의 혼합 용매를 사용하는 것이 바람직하다 Examples of such an organic solvent may be appropriately used a component capable of dissolving the above components, but preferably a solvent containing an oxygen atom, a solvent having an SP DS value of 1 or less and a solvent of 15 or more, represented by Equation 1 below. It is preferable to use a mixed solvent of
[수학식 1][Equation 1]
Figure PCTKR2013008783-appb-I000066
Figure PCTKR2013008783-appb-I000066
경화형 조성물에 사용되는 용매와 경화형 조성물이 도포되는 기재 필름과의 혼화성 및 부식의 정도는 용매 및 기재 필름의 용해도 상수(solubility parameter, SP)의 상관 관계로 알 수 있다. 상기 수학식 1 로 표현되는 SPDS 값이 1 이하인 용매는 기재 필름 표면을 일정량 이상 부식시킬 수 있다. 기재 필름의 표면을 일정량 녹이면 계면간의 요철 발생으로 무지개 현상을 막을 수 있으며, 밀착성, 코팅성 등이 향상될 수 있다. 하지만, 부식의 정도가 커서 계면간의 요철이 너무 커지면 헤이즈값이 상승하거나,백화 현상이 발생하고, 기계적인 물성, 특히 막강도 및 내굴곡성이 저하될 수 있다. 따라서, 기재 필름 표면의 부식성이 큰 상기 SPDS 값이 1 이하인 용매와 부식의 정도가 작은 SPDS 값이 15 이상인 용매를 동시에 2종 이상 혼합하여 사용하는 것이 바람직하다. SPDS 값이 1 이하인 용매만 사용하면, 백화 및 헤이즈 증가 현상이 있을 수 있고, SPDS 값이 15 이상인 용매만 사용하면 무지개 현상이 나타나고, 밀착성이 감소할 수 있다.The degree of miscibility and corrosion between the solvent used in the curable composition and the base film to which the curable composition is applied can be known by correlation of the solubility parameter (SP) of the solvent and the base film. A solvent having an SP DS value of 1 or less represented by Equation 1 may corrode the surface of the base film to a predetermined amount or more. When the surface of the base film is melted in a predetermined amount, the rainbow phenomenon may be prevented due to the occurrence of irregularities between the interfaces, and adhesion, coating property, and the like may be improved. However, if the degree of corrosion is large and the unevenness between the interfaces is too large, the haze value may increase, or whitening may occur, and mechanical properties, in particular, film strength and flex resistance may be reduced. Therefore, it is preferable to mix and use 2 or more types of solvents with the said SP DS value of 1 or less which are highly corrosive on the surface of a base film, and the solvent whose SP DS value is 15 or more of small degree of corrosion simultaneously. When only a solvent having an SP DS value of 1 or less is used, whitening and haze increase may occur. When only a solvent having an SP DS value of 15 or more is used, a rainbow phenomenon may occur and adhesion may be reduced.
상기 기재 필름과 용매의 SP는 당분야에 공지되어 있는 값을 사용할 수 있으며, 예를 들면, "Polymer Handbook(4thEd. J. Brandrup 외)"의 VII/671-VII/714에 제시되어 있는 값을 사용할 수 있다. 일반적으로 SP는 (ΔH/V)1/2로 정의할 수 있으며, ΔH는 몰 증발 엔탈피, V는 몰 부피를 나타낸다.The SP of the base film and the solvent may use values known in the art, for example, the values set forth in VII / 671-VII / 714 of the Polymer Handbook (4th Ed. J. Brandrup et al.). Can be used. In general, SP can be defined as (ΔH / V) 1/2, ΔH is the molar evaporation enthalpy, and V is the molar volume.
사용가능한 용매의 보다 구체적인 예시로는, 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 에틸렌글리콜모노프로필에테르, 에틸렌글리콜모노부틸에테르, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜에틸메틸에테르, 디에틸렌글리콜디프로필에테르, 디에틸렌글리콜디부틸에테르, ?메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 에틸렌글리콜모노부틸에테르아세테이트, 에틸렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노메틸에테르아세테이트, 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 메톡시부틸아세테이트, 메톡시펜틸아세테이트, 프로필렌글리콜모노메틸에테르, 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르, 프로필렌글리콜디메틸에테르, 프로필렌글리콜디에틸에테르, 프로필렌글리콜에틸메틸에테르, 프로필렌글리콜디프로필에테르프로필렌글리콜프로필메틸에테르, 프로필렌글리콜에틸프로필에테르, 프로필렌글리콜메틸에테르프로피오네이트, 프로필렌글리콜에틸에테르프로피오네이트, 프로필렌글리콜프로필에테르프로피오네이트, 프로필렌글리콜부틸에테르프로피오네이트, 메톡시부틸알코올, 에톡시부틸알코올, 프로폭시부틸알코올, 부톡시부틸알코올, 메톡시부틸아세테이트, 에톡시부틸아세테이트, 프로폭시부틸아세테이트, 부톡시부틸아세테이트, 메톡시부틸프로피오네이트, 에톡시부틸프로피오네이트, 프로폭시부틸프로피오네이트, 부톡시부틸프로피오네이트, 디프로필렌글리콜디메틸에테르, 디프로필렌글리콜디에틸에테르, 디프로필렌글리콜메틸에틸에테르, 벤젠, 톨루엔, 자일렌, 메시틸렌, 메틸에틸케톤, 아세톤, 메틸아밀케톤, 메틸이소부틸케톤, 시클로헥사논, 에탄올, 프로판올, 부탄올, 헥산올, 시클로헥산올, 에틸렌글리콜, 글리세린, 아세트산메틸, 아세트산에틸, 아세트산프로필, 아세트산부틸, 2-히드록시프로피온산에틸, 2-히드록시-2-메틸프로피온산메틸, 2-히드록시-2-메틸프로피온산에틸, 히드록시아세트산메틸, 히드록시아세트산에틸, 히드록시아세트산부틸, 락트산메틸, 락트산에틸, 락트산프로필, 락트산부틸, 3-히드록시프로피온산메틸, 3-히드록시프로피온산에틸, 3-히드록시프로피온산프로필, 3-히드록시프로피온산부틸, 2-히드록시-3-메틸부탄산메틸, 메톡시아세트산메틸, 메톡시아세트산에틸, 메톡시아세트산프로필, 메톡시아세트산부틸, 에톡시아세트산메틸, 에톡시아세트산에틸, 에톡시아세트산프로필, 에톡시아세트산부틸, 프로폭시아세트산메틸, 프로폭시아세트산에틸, 프로폭시아세트산프로필, 프로폭시아세트산부틸, 부톡시아세트산메틸, 부톡시아세트산에틸, 부톡시아세트산프로필, 부톡시아세트산부틸, 2-메톡시프로피온산메틸, 2-메톡시프로피온산에틸, 2-메톡시프로피온산프로필, 2-메톡시프로피온산부틸, 2-에톡시프로피온산메틸, 2-에톡시프로피온산에틸, 2-에톡시프로피온산프로필, 2-에톡시프로피온산부틸, 2-부톡시프로피온산메틸, 2-부톡시프로피온산에틸, 2-부톡시프로피온산프로필, 2-부톡시프로피온산부틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-메톡시프로피온산프로필, 3-메톡시프로피온산부틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산프로필, 3-에톡시프로피온산부틸, 3-프로폭시프로피온산메틸, 3-프로폭시프로피온산에틸, 3-프로폭시프로피온산프로필, 3-프로폭시프로피온산부틸, 3-부톡시프로피온산메틸, 3-부톡시프로피온산에틸, 3-부톡시프로피온산프로필, 3-부톡시프로피온산부틸, 테트라히드로푸란, 피란, γ-부티로락톤 등의 용매 중에서 상기 SPDS 값을 만족하는 것을 채택하여 사용할 수 있다.More specific examples of the solvent that can be used include ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol Ethyl methyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, ethylene glycol monobutyl ether acetate, ethylene glycol monoethyl ether acetate, propylene glycol monomethyl ether Acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, methoxybutyl acetate, methoxypentyl acetate, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, Propylene glycol monobutyl ether, propylene glycol dimethyl ether, propylene glycol diethyl ether, propylene glycol ethyl methyl ether, propylene glycol dipropyl ether propylene glycol propyl methyl ether, propylene glycol ethyl propyl ether, propylene glycol methyl ether propionate, propylene glycol Ethyl ether propionate, propylene glycol propyl ether propionate, propylene glycol butyl ether propionate, methoxy butyl alcohol, ethoxy butyl alcohol, propoxy butyl alcohol, butoxy butyl alcohol, methoxy butyl acetate, ethoxy butyl Acetate, propoxybutyl acetate, butoxybutyl acetate, methoxybutyl propionate, ethoxybutyl propionate, propoxybutyl propionate, butoxybutyl propionate, dipropylene glycol dimethyl ether, dipropylene glycol Recalled diethyl ether, dipropylene glycol methyl ethyl ether, benzene, toluene, xylene, mesitylene, methyl ethyl ketone, acetone, methyl amyl ketone, methyl isobutyl ketone, cyclohexanone, ethanol, propanol, butanol, hexanol, Cyclohexanol, ethylene glycol, glycerin, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, ethyl 2-hydroxypropionate, methyl 2-hydroxy-2-methylpropionate, ethyl 2-hydroxy-2-methylpropionate, Methyl hydroxy acetate, ethyl hydroxy acetate, butyl acetate acetate, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, 3-hydroxypropionate methyl, 3-hydroxypropionate ethyl, 3-hydroxypropionate propyl, 3- Butyl hydroxypropionate, methyl 2-hydroxy-3-methylbutyrate, methyl methoxyacetate, ethyl methoxyacetate, methoxyacetic acid propyl, methoxyacetic acid moiety Methyl ethoxyacetate, ethoxyacetic acid ethyl, ethoxyacetic acid propyl, ethoxyacetic acetate, methyl propoxyacetate, ethyl propoxyacetate, propyl propoxyacetate, butyl propoxyacetate, methyl butoxyacetic acid, ethyl butoxyacetate Propyl butoxy acetate, butyl butoxy acetate, methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, butyl 2-methoxypropionate, methyl 2-ethoxypropionate, 2-ethoxy Ethyl propionate, propyl 2-ethoxypropionate, butyl 2-ethoxypropionate, methyl 2-butoxypropionate, ethyl 2-butoxypropionate, propyl 2-butoxypropionate, butyl 2-butoxypropionate, 3-methoxypropionic acid Methyl, 3-Methoxypropionate, 3-Methoxypropionate, 3-Methoxypropionate, 3-Ethoxypropionate, 3-Ethoxypropionate, 3- Propyl oxypropionate, butyl 3-ethoxy propionate, methyl 3-propoxypropionate, ethyl 3-propoxypropionate, propyl 3-propoxypropionate, butyl 3-propoxypropionate, 3-butoxy methyl propionate, 3-butoxy What satisfy | fills the said SP DS value can be employ | adopted and used among solvents, such as ethyl propionate, propyl 3-butoxy propionate, butyl 3-butoxypropionate, tetrahydrofuran, pyran, and (gamma) -butyrolactone.
본 발명에 유기 용매는 적절한 점도를 유지하기 위해 조성물 총 중량 100중량%를 기준으로 상기 성분들의 함량의 잔량으로 포함될 수 있다. The organic solvent in the present invention may be included as the balance of the content of the components based on 100% by weight of the total weight of the composition in order to maintain an appropriate viscosity.
본 발명의 경화성 수지 조성물은 필요에 따라 충진제, 경화제, 레벨링제, 밀착촉진제, 산화 방지제, 자외선 흡수제, 응집 방지제, 연쇄 이동제 등의 첨가제를 더 포함할 수 있다.Curable resin composition of this invention may further contain additives, such as a filler, a hardening | curing agent, a leveling agent, an adhesion promoter, antioxidant, a ultraviolet absorber, an aggregation inhibitor, a chain transfer agent, as needed.
상기와 같은 성분을 포함하는 본 발명의 경화성 수지 조성물은 광학 필름에 사용되어 층간 접착력을 향상시키며, 특히 표면이 평탄하지 못한 필름의 표면 평탄화에 유용하게 사용될 수 있다. 예를 들면, 고분자 비드를 함유하는 PMMA 기재필름을 사용한 리타더의 경우에 PMMA 기재와 배향막 사이에 수지층을 형성하여, 고분자 비드에 의한 PMMA 기재 표면의 요철을 덮어 평탄성을 확보하고 PMMA 기재와 배향막 사이의 접착력을 강화할 수 있다.Curable resin composition of the present invention containing the above components are used in the optical film to improve the interlayer adhesion, in particular can be useful for the surface planarization of the film is not flat surface. For example, in the case of a retarder using a PMMA substrate film containing polymer beads, a resin layer is formed between the PMMA substrate and the alignment film to cover the irregularities on the surface of the PMMA substrate by the polymer beads, thereby securing flatness and ensuring the PMMA substrate and the alignment film. Adhesion between can be strengthened.
본 발명의 광학 필름의 일 구현예로서 리타더는 기재 필름, 본 발명의 조성물로 형성된 수지층, 배향막 및 경화 액정층이 순차적으로 적층된 구조를 가지며, 이에 대해서 구체적으로 설명하면 다음과 같다.As an embodiment of the optical film of the present invention, the retarder has a structure in which a base film, a resin layer formed of the composition of the present invention, an alignment film, and a cured liquid crystal layer are sequentially stacked, which will be described in detail below.
본 발명에 따른 기재 필름은 당분야에서 통상적으로 사용되는 기재 필름을 특별한 제한 없이 사용될 수 있다.The base film according to the present invention can be used without particular limitation the base film commonly used in the art.
당분야에서 기재 필름으로는 통상적으로 투명한 필름이 사용되며, 예를 들면 TAC(triacetyl cellulose)계, COP(cyclo-olefin polymer)계, PMMA(poly (methyl methacrylate))계 중합체 등을 포함하는 필름이다. 기재 필름은 검화(safonification) 처리, 리모트 플라즈마(remote plasma) 처리, 직접 플라즈마(direct plasma) 처리, 단량체 플라즈마(monomer plasma) 처리 등과 같은 표면 처리가 된 것일 수도 있다. PMMA계 기재 필름을 사용하는 경우에는 우레탄 비드와 같은 고분자 비드를 기재 필름 내에 분산시켜 사용하는 것이 바람직하다.A transparent film is generally used as the base film in the art, and is, for example, a film including a triacetyl cellulose (TAC), a cyclo-olefin polymer (COP), a poly (methyl methacrylate) polymer, or the like. . The base film may be surface treated such as safonification treatment, remote plasma treatment, direct plasma treatment, monomer plasma treatment, or the like. When using a PMMA type base film, it is preferable to disperse | distribute a polymeric bead like a urethane bead in a base film, and to use it.
본 발명에 따른 배향막은 당분야에서 통상적으로 사용되는 배향제, 중합 개시제 및 유기용매를 포함하는 배향막 형성용 조성물로 형성될 수 있다. 배향제로는 당분야에서 통상적으로 사용되는 배향제가 특별한 제한 없이 사용될 수 있다. 예를 들면 신나메이트기를 포함하며 중량평균 분자량이 10,000-500,000 정도인 고분자가 사용될 수 있으나, 이에 한정되는 것은 아니다. 중합 개시제로는 당분야에서 통상적으로 사용하는 광중합 개시제 또는 열중합 개시제가 사용될 수 있다. 광중합 개시제로는 앞서 예시한 광중합 개시제가 사용될 수 있다. 유기 용매 역시 앞서 예시한 유기 용매 중에서 적절하게 선택하여 사용할 수 있다.The alignment film according to the present invention may be formed of a composition for forming an alignment film including an alignment agent, a polymerization initiator, and an organic solvent commonly used in the art. As the alignment agent, an alignment agent conventionally used in the art may be used without particular limitation. For example, a polymer having a cinnamate group and having a weight average molecular weight of about 10,000-500,000 may be used, but is not limited thereto. As the polymerization initiator, a photopolymerization initiator or a thermal polymerization initiator commonly used in the art may be used. As the photopolymerization initiator, the photopolymerization initiators exemplified above may be used. An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
본 발명에 따른 경화 액정층은 말단에 중합성 관능기를 갖는 액정성 화합물, 중합 개시제 및 유기용매를 포함하는 조성물을 경화시켜 제조될 수 있으며, 중합 개시제로는 당분야에서 통상적으로 사용하는 광중합 개시제 또는 열중합 개시제가 사용될 수 있고, 광중합 개시제로는 앞서 예시한 광중합 개시제가 사용될 수 있다. 유기 용매 역시 앞서 예시한 유기 용매 중에서 적절하게 선택하여 사용할 수 있다.The cured liquid crystal layer according to the present invention may be prepared by curing a composition comprising a liquid crystal compound, a polymerization initiator, and an organic solvent having a polymerizable functional group at the terminal, and as a polymerization initiator, a photopolymerization initiator commonly used in the art or A thermal polymerization initiator may be used, and the photopolymerization initiator exemplified above may be used as the photopolymerization initiator. An organic solvent may also be appropriately selected from among the organic solvents exemplified above.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 이들 실시예는 본 발명을 예시하는 것일 뿐 첨부된 특허청구범위를 제한하는 것이 아니며, 본 발명의 범주 및 기술사상 범위 내에서 실시예에 대한 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다. Hereinafter, preferred examples are provided to aid the understanding of the present invention, but these examples are merely illustrative of the present invention and are not intended to limit the scope of the appended claims, which are within the scope and spirit of the present invention. It is apparent to those skilled in the art that various changes and modifications can be made to the present invention, and such modifications and changes belong to the appended claims.
실시예 1-6 및 비교예 1-5Example 1-6 and Comparative Example 1-5
하기 표 1에 기재된 조성으로 광중합 개시제, 제1 단량체, 제2 단량체, 레벨링제, 유기용매를 혼합하여 경화성 수지 조성물을 제조하였다(단위: g).A curable resin composition was prepared by mixing a photopolymerization initiator, a first monomer, a second monomer, a leveling agent, and an organic solvent in the composition shown in Table 1 below (unit: g).
표 1
Figure PCTKR2013008783-appb-T000001
Table 1
Figure PCTKR2013008783-appb-T000001
실험예Experimental Example
제조된 실시예1-6 및 비교예1-5의 조성물을 PMMA Film에 도포하고 100℃에서 30초간 건조를 실시한 후, 노광을 30mJ 각각 실시하여 수지층을 생성하였다.해당 공정후 수지층위에 광배향 조성물을 도포하고 100℃에서 50초간 건조를 실시한 후, 노광을 20mJ 각각 실시하여 배향막을 형성하였다. 배향막 상에 말단에 탄소-탄소 불포화 결합을 갖는 액정성 화합물을 포함하는 경화형 액정 조성물(RMS)을 도포하고 60℃의 온도에서 1분간 건조시킨 후, 1J 노광하여 경화반응을 유도하여 위상차 필름을 제조하였다.The prepared compositions of Example 1-6 and Comparative Examples 1-5 were applied to the PMMA film, dried at 100 ° C. for 30 seconds, and then exposed to 30 mJ, respectively, to form a resin layer. After apply | coating an orientation composition and drying at 100 degreeC for 50 second, exposure was performed each 20mJ, and the alignment film was formed. Applying a curable liquid crystal composition (RMS) comprising a liquid crystal compound having a carbon-carbon unsaturated bond on the terminal on the alignment film and dried for 1 minute at a temperature of 60 ℃, 1J exposure to induce a curing reaction to prepare a retardation film It was.
<배향각><Orientation angle>
루케오사의 WPA-100L 장비로 제조된 위상차 필름의 A, B Pattern중 A의 배향각을 측정하였다 The orientation angles of A in the A and B patterns of the retardation film manufactured by the Wake-100L equipment of Lukeo Corp. were measured.
◎ ; 45° ± 3 (A pattern 경우) , 135° ± 3 (B pattern 경우)◎; 45 ° ± 3 (A pattern), 135 ° ± 3 (B pattern)
○ : 45° ± 6 미만 (A pattern 경우) , 135° ± 6 미만 (B pattern 경우)○: Less than 45 ° ± 6 (A pattern), Less than 135 ° ± 6 (B pattern)
X : 45° ± 6 이상 (A pattern 경우) , 135° ± 6 이상 (B pattern 경우)X: 45 ° ± 6 or more (A pattern), 135 ° ± 6 or more (B pattern)
<경화도><Hardness degree>
PMMA상에 경화성 수지 조성물을 도포후 건조, 노광하여 FT-IR로 경화도 측정After coating curable resin composition on PMMA, drying and exposing, curing degree by FT-IR
◎ ; 95% 이상 ◎; More than 95%
○ : 85% 미만○: less than 85%
△ : 75% 미만△: less than 75%
× : 65% 미만×: less than 65%
<표면조도><Surface roughness>
PMMA상에 경화성 수지 조성물을 도포 후 건조, 노광하여 경화성 수지 조성물 표면조도를 측정.After apply | coating curable resin composition on PMMA, it dries and exposes and measures surface roughness of curable resin composition.
◎ ; Ra 값 2.0미만 ◎; Ra value less than 2.0
○ : Ra 값 2~5.(Circle): Ra value 2-5.
△ : Ra 값 5~10△: Ra value 5-10
× : Ra 값 12이상×: Ra value 12 or more
<층간 접착력><Layer adhesion>
생성된 패턴을 광학현미경을 통하여 평가하였을 때 아래와 같은 패턴상에 뜯김 현상 정도로 평가하였다. When the generated pattern was evaluated through an optical microscope, the degree of tearing was evaluated on the following pattern.
◎ ; 패턴상 뜯김 없음◎; No tearing on the pattern
○ : 패턴상 뜯김 1~3개○: 1 to 3 tearing patterns
△ : 패턴상 뜯김 4~8개△: 4 to 8 tears on the pattern
× : 패턴상 뜯김 8개 초과×: more than 8 tears in pattern
표 2
Figure PCTKR2013008783-appb-T000002
TABLE 2
Figure PCTKR2013008783-appb-T000002
위 표 2에 기재된 바와 같이, 본 발명에 따른 경화층을 구비한 실시예들의 리타더는 비교예들의 리타더 대비 수지층의 경화도, 표면조도 및 층간 접착력 측면에서 전반적으로 우수한 것을 확인할 수 있다. 특히 실시예 1의 경우에는 광중합 개시제가 이량화된 구조를 가져 광활성 부위(site)가 통상적인 경우보다 2배가 되므로, 다른 성분들은 동일하게 사용한 실시예 2보다 경화도가 보다 더 우수한 것을 확인할 수 있다.As described in Table 2 above, the retarder of the embodiments provided with a cured layer according to the present invention can be confirmed that the overall excellent in terms of curing degree, surface roughness and interlayer adhesion of the resin layer compared to the retarder of the comparative examples. Particularly, in Example 1, since the photopolymerization initiator has a dimerized structure, the photoactive site is twice as large as that in the conventional case, and it can be confirmed that other components are more excellent in curing degree than Example 2, which was used in the same manner.

Claims (15)

  1. 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제; 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체; 히드록시기 또는 카르복시기를 갖는 다관능 제2 단량체; 및 유기용매를 포함하는 경화성 수지 조성물.Photopolymerization initiators having at least two photoactive oxime ester backbones in one molecule; A first monomer capable of photocuring and thermosetting by including an isocyanate group and a (meth) acrylate group at its terminals; Polyfunctional second monomer having a hydroxy group or a carboxy group; And an organic solvent.
  2. 청구항 1에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 1로 표시되는 화합물이 R1 또는 R2를 통해 이량화된 것인 경화성 수지 조성물:The curable resin composition of claim 1, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is dimerized through R 1 or R 2 .
    [화학식 1][Formula 1]
    Figure PCTKR2013008783-appb-I000067
    Figure PCTKR2013008783-appb-I000067
    (식 중, R1, R2 및 R3은 서로 독립적으로 R11, OR11, COR11, SR11, CONR12R13 또는 CN을 나타내고,Wherein R 1 , R 2 and R 3 independently of one another represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or CN,
    R4 및 R5는 각각 독립적으로 R11, OR11, SR11, COR11, CONR12R13, NR12COR11, OCOR11, COOR11, SCOR11, OCSR11, COSR11, CSOR11, CN, 할로겐원자 또는 히드록시기를 나타내고,R 4 and R 5 are each independently R 11 , OR 11 , SR 11 , COR 11 , CONR 12 R 13 , NR 12 COR 11 , OCOR 11 , COOR 11 , SCOR 11 , OCSR 11 , COSR 11 , CSOR 11 , CN Represents a halogen atom or a hydroxy group,
    a 및 b는 서로 독립적으로 0 내지 3인 정수이고,a and b are each independently an integer of 0 to 3,
    R11, R12 및 R13은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며, 여기에서 알킬기, 아릴기, 아릴알킬기 및 복소환기의 수소원자는, 또한 R21, OR21, COR21, SR21, NR22R23, CON R22R23, -NR22-OR23, -NCOR22-OCOR23, -C(=N-OR21)-R22, -C(=N-OCOR21)-R22, CN, 할로겐원자, -CR21=CR22R23, -CO-CR21=CR22R23, OCO-CR21=CR22R23, O-C1-6알킬렌-OCOR21, COOR21, 에폭시기로 치환되어 있어도 되고, R 11 , R 12 and R 13 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Wherein the hydrogen atom of the alkyl group, aryl group, arylalkyl group and heterocyclic group is also R 21 , OR 21 , COR 21 , SR 21 , NR 22 R 23 , CON R 22 R 23 , -NR 22 -OR 23 , -NCOR 22 -OCOR 23 , -C (= N-OR 21 ) -R 22 , -C (= N-OCOR 21 ) -R 22 , CN, halogen atom, -CR 21 = CR 22 R 23 , -CO- CR 21 = CR 22 R 23 , OCO-CR 21 = CR 22 R 23 , OC 1-6 alkylene-OCOR 21 , COOR 21 , or may be substituted with an epoxy group,
    R21, R22 및 R23은 서로 독립적으로 수소원자, 탄소원자수 1 내지 20인 알킬기, 탄소원자수 6 내지 30인 아릴기, 탄소원자수 7 내지 30인 아릴알킬기 또는 탄소원자수 2 내지 20인 복소환기를 나타내며,R 21 , R 22 and R 23 are each independently a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an aryl group having 6 to 30 carbon atoms, an arylalkyl group having 7 to 30 carbon atoms or a heterocyclic group having 2 to 20 carbon atoms Indicates,
    상기 R11, R12, R13, R21, R22 및 R23으로 표시되는 치환기의 알킬렌 부분의 메틸렌기는 불포화 결합, 에테르 결합, 티오에테르 결합, 에스테르 결합, 티오에스테르 결합, 아미드 결합 또는 우레탄 결합에 의해 1 내지 5회 중단되어 있어도 되고, 상기 치환기의 알킬 부분은 분기측쇄가 있어도 되고, 환상 알킬이어도 되며, 상기 치환기의 알킬 말단은 불포화 결합이어도 되고, 또한 R12와 R13및 R22와 R23은 각각 함께 환을 형성하고 있어도 되며, R3은 인접하는 벤젠환과 함께 환을 형성하고 있어도 된다.)The methylene group of the alkylene moiety of the substituent represented by R 11 , R 12 , R 13 , R 21 , R 22 and R 23 is an unsaturated bond, ether bond, thioether bond, ester bond, thioester bond, amide bond or urethane It may be interrupted 1 to 5 times by a bond, the alkyl moiety of the substituent may have a branched chain, a cyclic alkyl, the alkyl terminal of the substituent may be an unsaturated bond, and R 12 , R 13 and R 22 and R 23 may each form a ring together, and R 3 may form a ring together with an adjacent benzene ring.)
  3. 청구항 2에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 2 또는 화학식 3으로 표시되는 화합물인 경화성 수지 조성물:The curable resin composition of claim 2, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is a compound represented by the following Chemical Formula 2 or Formula 3:
    [화학식 2][Formula 2]
    Figure PCTKR2013008783-appb-I000068
    Figure PCTKR2013008783-appb-I000068
    [화학식 3][Formula 3]
    Figure PCTKR2013008783-appb-I000069
    Figure PCTKR2013008783-appb-I000069
    (식 중, R1 내지 R5는 청구항 2에서 정의된 바와 같음).Wherein R 1 to R 5 are as defined in claim 2.
  4. 청구항 1에 있어서, 상기 한 분자내에 적어도 2개의 광활성 옥심 에스테르 골격을 갖는 광중합 개시제는 하기 화학식 11로 표시되는 화합물인 것을 특징으로 하는 경화성 수지 조성물:The curable resin composition according to claim 1, wherein the photopolymerization initiator having at least two photoactive oxime ester skeletons in one molecule is a compound represented by the following general formula (11):
    [화학식 11][Formula 11]
    Figure PCTKR2013008783-appb-I000070
    Figure PCTKR2013008783-appb-I000070
  5. 청구항 1에 있어서, 상기 이소시아네이트기 및 (메타)아크릴레이트기를 그 말단에 포함하여 광경화 및 열경화가 가능한 제1 단량체는 하기 화학식 16 내지 19의 화합물로 이루어진 군에서 선택된 1 종 이상의 것인 경화성 수지 조성물:The curable resin according to claim 1, wherein the first monomer capable of photocuring and thermosetting including an isocyanate group and a (meth) acrylate group at its terminal is one or more selected from the group consisting of compounds represented by Formulas 16 to 19: Composition:
    [화학식 16][Formula 16]
    Figure PCTKR2013008783-appb-I000071
    Figure PCTKR2013008783-appb-I000071
    (식 중, R1 및 R2는 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 1 and R 2 are each independently hydrogen or a methyl group,
    R3 및 R7은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 3 and R 7 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R4 및 R6은 서로 독립적으로 아미드기, 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 4 and R 6 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of an amide group, a ketone group, an ester group and a thiol group,
    R5는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),R 5 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with an alkoxy group having 1 to 8 carbon atoms,
    [화학식 17][Formula 17]
    Figure PCTKR2013008783-appb-I000072
    Figure PCTKR2013008783-appb-I000072
    (식 중, R7 및 R8은 서로 독립적으로 수소 또는 메틸기이고,(Wherein R 7 and R 8 are each independently hydrogen or a methyl group,
    R9 및 R11은 서로 독립적으로 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기이고,R 9 and R 11 are each independently an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group,
    R10는 (a)
    Figure PCTKR2013008783-appb-I000073
    또는 (b)
    Figure PCTKR2013008783-appb-I000074
    이고, E1 및 E3는 서로 독립적으로 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 탄소수 1 내지 8의 알콕시기이고, E2는 탄소수 1 내지 8의 알콕시기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임),
    R 10 is (a)
    Figure PCTKR2013008783-appb-I000073
    Or (b)
    Figure PCTKR2013008783-appb-I000074
    E 1 and E 3 are each independently a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 8 carbon atoms, and E 2 is an alkoxy group having 1 to 8 carbon atoms. Substituted or unsubstituted alkylene group having 1 to 10 carbon atoms,
    [화학식 18][Formula 18]
    Figure PCTKR2013008783-appb-I000075
    Figure PCTKR2013008783-appb-I000075
    (식 중, R12는 수소 또는 메틸기이고,(Wherein R 12 is hydrogen or a methyl group,
    R13은 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임) 및R 13 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group; and
    [화학식 19][Formula 19]
    Figure PCTKR2013008783-appb-I000076
    Figure PCTKR2013008783-appb-I000076
    (식 중, R14는 수소 또는 메틸기이고,(Wherein, R 14 is hydrogen or a methyl group,
    R15는 케톤기, 에스테르기 및 티올기로 이루어진 군에서 선택된 기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬렌기임).R 15 is an alkylene group having 1 to 10 carbon atoms unsubstituted or substituted with a group selected from the group consisting of a ketone group, an ester group and a thiol group.
  6. 청구항 1에 있어서, 상기 히드록시기를 갖는 다관능 제2 단량체는 하기 화학식 31로 표시되는 것인 경화성 수지 조성물:The curable resin composition of claim 1, wherein the multifunctional second monomer having a hydroxyl group is represented by the following Chemical Formula 31:
    [화학식 31][Formula 31]
    (식 중, R1, R2, R3 및 R4 중 적어도 하나는 수소 또는 카르복시기이고 나머지는 서로 독립적으로 메틸기 또는 아크릴로일기에서 선택되며, A는
    Figure PCTKR2013008783-appb-I000078
    ,
    Figure PCTKR2013008783-appb-I000079
    ,
    Figure PCTKR2013008783-appb-I000080
    ,
    Figure PCTKR2013008783-appb-I000081
    ,
    Figure PCTKR2013008783-appb-I000082
    또는
    Figure PCTKR2013008783-appb-I000083
    에서 선택되며, a는 1 내지 3의 정수이고, b는 0 내지 12의 정수임).
    Wherein at least one of R 1 , R 2 , R 3 and R 4 is hydrogen or a carboxy group and the rest are independently selected from methyl or acryloyl groups, and A is
    Figure PCTKR2013008783-appb-I000078
    ,
    Figure PCTKR2013008783-appb-I000079
    ,
    Figure PCTKR2013008783-appb-I000080
    ,
    Figure PCTKR2013008783-appb-I000081
    ,
    Figure PCTKR2013008783-appb-I000082
    or
    Figure PCTKR2013008783-appb-I000083
    Is a integer of 1 to 3, b is an integer of 0 to 12).
  7. 청구항 1에 있어서, 제2 단량체는 폴리스티렌 환산의 중량평균 분자량이 200 내지 3,000인 경화성 수지 조성물.The curable resin composition according to claim 1, wherein the second monomer has a weight average molecular weight in terms of polystyrene of 200 to 3,000.
  8. 청구항 1에 있어서, 제1 단량체와 제2 단량체의 혼합 중량비는 제1 단량체:제2 단량체 = 1:1-2인 경화성 수지 조성물.The curable resin composition of Claim 1 whose mixing weight ratio of a 1st monomer and a 2nd monomer is 1st monomer: 2nd monomer = 1: 1-2.
  9. 청구항 1에 있어서, 상기 유기 용매는 하기 수학식 1로 표시되는 SPDS값이 1 이하인 용매와 15 이상인 용매의 혼합 용매인 경화성 수지 조성물:The curable resin composition of claim 1, wherein the organic solvent is a mixed solvent of a solvent having an SP DS value of 1 or less and a solvent of 15 or more represented by the following Equation 1:
    [수학식 1][Equation 1]
    Figure PCTKR2013008783-appb-I000084
    Figure PCTKR2013008783-appb-I000084
    (식 중, SPSUB 는 기재 필름의 SP값이고, SPSOL 은 용매의 SP 값임).(In formula, SP SUB is SP value of a base film, SP SOL is SP value of a solvent.).
  10. 청구항 1 내지 9 중 어느 한 항의 경화성 수지 조성물로 경화된 수지층을 구비하는 광학 필름.The optical film provided with the resin layer hardened | cured with curable resin composition of any one of Claims 1-9.
  11. 청구항 10에 있어서, 상기 광학 필름은 리타더인 광학 필름.The optical film of claim 10, wherein the optical film is a retarder.
  12. 청구항 11에 있어서, 상기 리타더는 상기 수지층이 기재 필름과 배향막 사이에 개재되는 구조를 구비하는 광학 필름.The optical film according to claim 11, wherein the retarder has a structure in which the resin layer is interposed between the base film and the alignment film.
  13. 청구항 12에 있어서, 상기 기재 필름은 PMMA 수지를 포함하여 형성된 것인 광학 필름.The optical film of claim 12, wherein the base film is formed including a PMMA resin.
  14. 청구항 13에 있어서, 상기 기재 필름과 수지층 사이에는 탄소-탄소 포화결합이 존재하는 광학 필름.The optical film of claim 13, wherein a carbon-carbon saturated bond exists between the base film and the resin layer.
  15. 청구항 10의 광학 필름을 구비하는 화상 표시 장치.An image display device comprising the optical film of claim 10.
PCT/KR2013/008783 2012-10-23 2013-10-01 Hardening resin composition and optical film manufactured by using same WO2014065517A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120117990A KR20140052233A (en) 2012-10-23 2012-10-23 Curable resin composition and optical film prepared by using the same
KR10-2012-0117990 2012-10-23

Publications (1)

Publication Number Publication Date
WO2014065517A1 true WO2014065517A1 (en) 2014-05-01

Family

ID=50544859

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/008783 WO2014065517A1 (en) 2012-10-23 2013-10-01 Hardening resin composition and optical film manufactured by using same

Country Status (3)

Country Link
KR (1) KR20140052233A (en)
TW (1) TW201416391A (en)
WO (1) WO2014065517A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014177641A (en) * 2014-05-29 2014-09-25 Shinnakamura Kagaku Kogyo Kk Urethane (meth)acrylate and photocurable resin composition containing the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016194563A (en) * 2015-03-31 2016-11-17 太陽インキ製造株式会社 Conductive resin composition and conductive circuit
CN109970885B (en) * 2019-03-21 2021-03-23 江南大学 Long conjugated carbazolyl oxime ester photoinitiator and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11349947A (en) * 1998-06-05 1999-12-21 Nippon Mitsubishi Oil Corp Photocurable liquid crystal composition and liquid crystal film
JP2005097141A (en) * 2003-09-24 2005-04-14 Asahi Denka Kogyo Kk Dimer oxime ester compound and photopolymerization initiator comprising the same compound as active ingredient
US20110045290A1 (en) * 2008-03-03 2011-02-24 Lintec Corporation Adhesive Sheet
KR20120019619A (en) * 2010-08-26 2012-03-07 동우 화인켐 주식회사 A colored photosensitive resin composition, color filter and liquid crystal display device having the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11349947A (en) * 1998-06-05 1999-12-21 Nippon Mitsubishi Oil Corp Photocurable liquid crystal composition and liquid crystal film
JP2005097141A (en) * 2003-09-24 2005-04-14 Asahi Denka Kogyo Kk Dimer oxime ester compound and photopolymerization initiator comprising the same compound as active ingredient
US20110045290A1 (en) * 2008-03-03 2011-02-24 Lintec Corporation Adhesive Sheet
KR20120019619A (en) * 2010-08-26 2012-03-07 동우 화인켐 주식회사 A colored photosensitive resin composition, color filter and liquid crystal display device having the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014177641A (en) * 2014-05-29 2014-09-25 Shinnakamura Kagaku Kogyo Kk Urethane (meth)acrylate and photocurable resin composition containing the same

Also Published As

Publication number Publication date
TW201416391A (en) 2014-05-01
KR20140052233A (en) 2014-05-07

Similar Documents

Publication Publication Date Title
WO2015108386A1 (en) Novel β-oximester fluorene compound, a photopolymerization initiator comprising same, and photoresist composition
WO2017047917A1 (en) Modified polyimide and curable resin composition containing same
WO2015016456A1 (en) Retardation film and image display device having same
WO2010053298A2 (en) Lyotropic chromonic liquid crystal composition, method for manufacture of lyotropic chromonic liquid crystal coating film, and lyotropic chromonic liquid crystal coating film manufactured thereby
WO2015008925A1 (en) Polarising film and image display apparatus having same
WO2010093210A2 (en) Photoactive compound and photosensitive resin composition containing the same
WO2020139042A2 (en) Carbazole multi beta oxime ester derivative compound and photopolymerization initiator and photoresist composition comprising same
WO2017010768A1 (en) Cross-linkable composition
WO2018159975A1 (en) Polymer resin compound and photosensitive resin composition for black bank, comprising same
WO2012064097A2 (en) Photoresist topcoat composition for extreme ultraviolet lithography, and pattern-forming method using same
WO2020111522A1 (en) Photosensitive resin composition, film, and electronic device
WO2013051831A2 (en) Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same
WO2013094969A2 (en) Polarizing plate and image display device having same
WO2019022394A1 (en) Novel polymer for formation of resist underlayer film, composition for formation of resist underlayer film comprising same and method for manufacturing semiconductor element by using same
WO2014065517A1 (en) Hardening resin composition and optical film manufactured by using same
WO2015064958A1 (en) Novel oxime ester biphenyl compound, photo initiator and photosensitive resin composition containing same
WO2021132865A1 (en) Polymer resin compound, method for producing same, and photosensitive resin composition comprising same
WO2019107824A1 (en) Negative photosensitive resin composition and electronic device having organic insulating film using same
WO2020022670A1 (en) Binder resin, photosensitive resin composition, photoresist, color filter, and display device
WO2020130261A1 (en) Crosslinking agent compound, photosensitive composition including same, and photosensitive material using same
WO2021132924A1 (en) Encapsulation composition, encapsulation layer comprising same, and encapsulated apparatus comprising encapsulation layer
WO2014065515A1 (en) Composition for forming liquid crystal layer and retarder prepared by using same
WO2023022452A1 (en) Photosensitive resin composition and display device
WO2024085598A1 (en) Polymer
WO2023022472A1 (en) Photosensitive resin composition and display device including same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13849915

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13849915

Country of ref document: EP

Kind code of ref document: A1